Frequencies for first 10,000 rows of pt variable in reac2006q1 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 7 0.07 0.07 ABDOMINAL ABSCESS | 1 0.01 0.08 ABDOMINAL DISCOMFORT | 6 0.06 0.14 ABDOMINAL DISTENSION | 8 0.08 0.22 ABDOMINAL HAEMATOMA | 2 0.02 0.24 ABDOMINAL HERNIA | 2 0.02 0.26 ABDOMINAL MASS | 3 0.03 0.29 ABDOMINAL OPERATION | 1 0.01 0.30 ABDOMINAL PAIN | 40 0.40 0.70 ABDOMINAL PAIN LOWER | 1 0.01 0.71 ABDOMINAL PAIN UPPER | 13 0.13 0.84 ABDOMINAL STRANGULATED HERNIA | 1 0.01 0.85 ABDOMINAL TENDERNESS | 2 0.02 0.87 ABDOMINAL WALL ABSCESS | 1 0.01 0.88 ABNORMAL BEHAVIOUR | 7 0.07 0.95 ABNORMAL DREAMS | 1 0.01 0.96 ABORTION | 3 0.03 0.99 ABORTION INDUCED | 4 0.04 1.03 ABORTION SPONTANEOUS | 10 0.10 1.13 ABSCESS | 2 0.02 1.15 ABSCESS INTESTINAL | 1 0.01 1.16 ABSCESS LIMB | 2 0.02 1.18 ABULIA | 1 0.01 1.19 ACARODERMATITIS | 1 0.01 1.20 ACCESSORY AURICLE | 1 0.01 1.21 ACCIDENT | 1 0.01 1.22 ACCIDENT AT WORK | 3 0.03 1.25 ACCIDENTAL DEATH | 1 0.01 1.26 ACCIDENTAL DRUG INTAKE BY CHILD | 3 0.03 1.29 ACCIDENTAL EXPOSURE | 2 0.02 1.31 ACCIDENTAL NEEDLE STICK | 1 0.01 1.32 ACCIDENTAL OVERDOSE | 5 0.05 1.37 ACCOMMODATION DISORDER | 3 0.03 1.40 ACHOLIA | 1 0.01 1.41 ACIDOSIS | 4 0.04 1.45 ACNE | 3 0.03 1.48 ACROCHORDON | 1 0.01 1.49 ACTINIC KERATOSIS | 1 0.01 1.50 ACTINOMYCOSIS | 1 0.01 1.51 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 2 0.02 1.53 ACTIVITIES OF DAILY LIVING IMPAIRED | 4 0.04 1.57 ACUTE ABDOMEN | 1 0.01 1.58 ACUTE CORONARY SYNDROME | 6 0.06 1.64 ACUTE GENERALISED EXANTHEMATOUS PUSTU.. | 1 0.01 1.65 ACUTE MYELOID LEUKAEMIA | 1 0.01 1.66 ACUTE MYOCARDIAL INFARCTION | 29 0.29 1.95 ACUTE PRERENAL FAILURE | 1 0.01 1.96 ACUTE PULMONARY OEDEMA | 2 0.02 1.98 ACUTE RESPIRATORY DISTRESS SYNDROME | 6 0.06 2.04 ACUTE RESPIRATORY FAILURE | 5 0.05 2.09 ACUTE SINUSITIS | 1 0.01 2.10 ADRENAL MASS | 1 0.01 2.11 ADVERSE DRUG REACTION | 2 0.02 2.13 ADVERSE EVENT | 17 0.17 2.30 AFFECT LABILITY | 2 0.02 2.32 AFFECTIVE DISORDER | 3 0.03 2.35 AGEUSIA | 4 0.04 2.39 AGGRESSION | 17 0.17 2.56 AGITATION | 18 0.18 2.74 AGRANULOCYTOSIS | 8 0.08 2.82 AKATHISIA | 3 0.03 2.85 ALANINE AMINOTRANSFERASE DECREASED | 1 0.01 2.86 ALANINE AMINOTRANSFERASE INCREASED | 33 0.33 3.19 ALBUMINURIA | 1 0.01 3.20 ALCOHOL DETOXIFICATION | 1 0.01 3.21 ALCOHOL POISONING | 1 0.01 3.22 ALCOHOL USE | 3 0.03 3.25 ALCOHOL WITHDRAWAL SYNDROME | 1 0.01 3.26 ALCOHOLISM | 1 0.01 3.27 ALLODYNIA | 1 0.01 3.28 ALOPECIA | 16 0.16 3.44 ALOPECIA UNIVERSALIS | 1 0.01 3.45 ALPHA 1 FOETOPROTEIN INCREASED | 1 0.01 3.46 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECT.. | 1 0.01 3.47 ALVEOLITIS FIBROSING | 1 0.01 3.48 ALVEOLOPLASTY | 1 0.01 3.49 AMAUROSIS FUGAX | 1 0.01 3.50 AMENORRHOEA | 4 0.04 3.54 AMMONIA INCREASED | 3 0.03 3.57 AMNESIA | 20 0.20 3.77 AMYLOIDOSIS | 1 0.01 3.78 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 3.79 AMYOTROPHY | 1 0.01 3.80 ANAEMIA | 62 0.62 4.42 ANAEMIA MACROCYTIC | 1 0.01 4.43 ANAEMIA POSTOPERATIVE | 2 0.02 4.45 ANAEMIA VITAMIN B12 DEFICIENCY | 1 0.01 4.46 ANAL FISTULA | 1 0.01 4.47 ANAL HAEMORRHAGE | 1 0.01 4.48 ANAPHYLACTIC REACTION | 9 0.09 4.57 ANAPHYLACTIC SHOCK | 6 0.06 4.63 ANAPHYLACTOID REACTION | 2 0.02 4.65 ANAPLASTIC LARGE CELL LYMPHOMA T- AND.. | 1 0.01 4.66 ANASTOMOTIC COMPLICATION | 1 0.01 4.67 ANASTOMOTIC LEAK | 1 0.01 4.68 ANASTOMOTIC STENOSIS | 1 0.01 4.69 ANEURYSM | 4 0.04 4.73 ANGER | 2 0.02 4.75 ANGINA PECTORIS | 27 0.27 5.02 ANGINA UNSTABLE | 19 0.19 5.21 ANGIONEUROTIC OEDEMA | 11 0.11 5.32 ANHEDONIA | 4 0.04 5.36 ANIMAL BITE | 1 0.01 5.37 ANIMAL SCRATCH | 1 0.01 5.38 ANION GAP | 1 0.01 5.39 ANION GAP ABNORMAL | 1 0.01 5.40 ANKLE FRACTURE | 1 0.01 5.41 ANKYLOGLOSSIA ACQUIRED | 1 0.01 5.42 ANKYLOSING SPONDYLITIS | 1 0.01 5.43 ANORECTAL DISORDER | 1 0.01 5.44 ANOREXIA | 24 0.24 5.68 ANOSMIA | 2 0.02 5.70 ANOXIC ENCEPHALOPATHY | 4 0.04 5.74 ANTI FACTOR V ANTIBODY POSITIVE | 1 0.01 5.75 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE | 1 0.01 5.76 ANTI-SS-A ANTIBODY POSITIVE | 1 0.01 5.77 ANTICONVULSANT DRUG LEVEL ABOVE THERA.. | 1 0.01 5.78 ANTICONVULSANT DRUG LEVEL BELOW THERA.. | 1 0.01 5.79 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY P.. | 1 0.01 5.80 ANTINUCLEAR ANTIBODY POSITIVE | 2 0.02 5.82 ANURIA | 1 0.01 5.83 ANXIETY | 67 0.67 6.50 AORTIC ANEURYSM | 2 0.02 6.52 AORTIC ANEURYSM RUPTURE | 2 0.02 6.54 AORTIC ARTERIOSCLEROSIS | 3 0.03 6.57 AORTIC DILATATION | 1 0.01 6.58 AORTIC DISSECTION | 2 0.02 6.60 AORTIC INJURY | 1 0.01 6.61 AORTIC VALVE CALCIFICATION | 1 0.01 6.62 AORTIC VALVE INCOMPETENCE | 5 0.05 6.67 AORTIC VALVE SCLEROSIS | 1 0.01 6.68 AORTIC VALVE STENOSIS | 3 0.03 6.71 APATHY | 1 0.01 6.72 APGAR SCORE LOW | 1 0.01 6.73 APHAGIA | 1 0.01 6.74 APHASIA | 4 0.04 6.78 APHONIA | 1 0.01 6.79 APHTHOUS STOMATITIS | 5 0.05 6.84 APLASIA | 1 0.01 6.85 APLASIA PURE RED CELL | 6 0.06 6.91 APLASTIC ANAEMIA | 2 0.02 6.93 APNOEA | 3 0.03 6.96 APPENDICITIS | 1 0.01 6.97 APPENDICITIS PERFORATED | 1 0.01 6.98 APPETITE DISORDER | 1 0.01 6.99 APPLICATION SITE ERYTHEMA | 2 0.02 7.01 APPLICATION SITE IRRITATION | 1 0.01 7.02 APPLICATION SITE PRURITUS | 1 0.01 7.03 APRAXIA | 2 0.02 7.05 AREFLEXIA | 1 0.01 7.06 ARRHYTHMIA | 21 0.21 7.27 ARTERIAL DISORDER | 1 0.01 7.28 ARTERIAL FIBROSIS | 1 0.01 7.29 ARTERIAL HAEMORRHAGE | 1 0.01 7.30 ARTERIAL OCCLUSIVE DISEASE | 8 0.08 7.38 ARTERIAL RUPTURE | 2 0.02 7.40 ARTERIAL STENOSIS | 1 0.01 7.41 ARTERIAL STENOSIS LIMB | 1 0.01 7.42 ARTERIAL THROMBOSIS | 1 0.01 7.43 ARTERIAL THROMBOSIS LIMB | 1 0.01 7.44 ARTERIOSCLEROSIS | 13 0.13 7.57 ARTERIOSCLEROSIS CORONARY ARTERY | 16 0.16 7.73 ARTERIOSPASM CORONARY | 1 0.01 7.74 ARTERIOVENOUS FISTULA SITE INFECTION | 1 0.01 7.75 ARTERITIS | 1 0.01 7.76 ARTERY DISSECTION | 1 0.01 7.77 ARTHRALGIA | 46 0.46 8.23 ARTHRITIS | 14 0.14 8.37 ARTHRITIS BACTERIAL | 1 0.01 8.38 ARTHRITIS INFECTIVE | 1 0.01 8.39 ARTHROPATHY | 18 0.18 8.57 ARTHROPOD BITE | 3 0.03 8.60 ARTIFICIAL RUPTURE OF MEMBRANES | 1 0.01 8.61 ASBESTOSIS | 2 0.02 8.63 ASCITES | 8 0.08 8.71 ASPARTATE AMINOTRANSFERASE DECREASED | 1 0.01 8.72 ASPARTATE AMINOTRANSFERASE INCREASED | 33 0.33 9.05 ASPERGILLOSIS | 1 0.01 9.06 ASPIRATION | 3 0.03 9.09 ASTHENIA | 62 0.62 9.71 ASTHENOPIA | 1 0.01 9.72 ASTHMA | 16 0.16 9.88 ATELECTASIS | 7 0.07 9.95 ATRIAL FIBRILLATION | 42 0.42 10.37 ATRIAL FLUTTER | 3 0.03 10.40 ATRIAL TACHYCARDIA | 2 0.02 10.42 ATRIOVENTRICULAR BLOCK | 3 0.03 10.45 ATRIOVENTRICULAR BLOCK COMPLETE | 3 0.03 10.48 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 3 0.03 10.51 ATRIOVENTRICULAR BLOCK SECOND DEGREE | 3 0.03 10.54 ATROPHIC VULVOVAGINITIS | 1 0.01 10.55 AUTISM SPECTRUM DISORDER | 1 0.01 10.56 AUTOIMMUNE DISORDER | 1 0.01 10.57 AUTOIMMUNE HEPATITIS | 1 0.01 10.58 AZOTAEMIA | 2 0.02 10.60 B-CELL LYMPHOMA | 2 0.02 10.62 BACK DISORDER | 6 0.06 10.68 BACK INJURY | 7 0.07 10.75 BACK PAIN | 42 0.42 11.17 BACTERAEMIA | 2 0.02 11.19 BACTERIA BLOOD IDENTIFIED | 2 0.02 11.21 BACTERIA STOOL IDENTIFIED | 1 0.01 11.22 BACTERIAL INFECTION | 4 0.04 11.26 BACTERIAL SEPSIS | 2 0.02 11.28 BALANCE DISORDER | 5 0.05 11.33 BARRETT'S OESOPHAGUS | 1 0.01 11.34 BASAL CELL CARCINOMA | 4 0.04 11.38 BENIGN COLONIC NEOPLASM | 1 0.01 11.39 BENIGN INTRACRANIAL HYPERTENSION | 3 0.03 11.42 BENIGN PANCREATIC NEOPLASM | 1 0.01 11.43 BENIGN PROSTATIC HYPERPLASIA | 3 0.03 11.46 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION | 1 0.01 11.47 BILIARY CIRRHOSIS | 2 0.02 11.49 BILIARY COLIC | 5 0.05 11.54 BILIRUBIN CONJUGATED INCREASED | 1 0.01 11.55 BIOPSY LUNG | 1 0.01 11.56 BIPOLAR DISORDER | 1 0.01 11.57 BLADDER CANCER | 3 0.03 11.60 BLADDER DISORDER | 1 0.01 11.61 BLADDER SPASM | 1 0.01 11.62 BLEPHAROSPASM | 1 0.01 11.63 BLINDNESS | 2 0.02 11.65 BLINDNESS TRANSIENT | 1 0.01 11.66 BLINDNESS UNILATERAL | 8 0.08 11.74 BLISTER | 7 0.07 11.81 BLOOD ALBUMIN DECREASED | 5 0.05 11.86 BLOOD ALKALINE PHOSPHATASE INCREASED | 19 0.19 12.05 BLOOD AMYLASE DECREASED | 1 0.01 12.06 BLOOD AMYLASE INCREASED | 2 0.02 12.08 BLOOD BILIRUBIN DECREASED | 1 0.01 12.09 BLOOD BILIRUBIN INCREASED | 12 0.12 12.21 BLOOD CALCIUM DECREASED | 2 0.02 12.23 BLOOD CALCIUM INCREASED | 1 0.01 12.24 BLOOD CHLORIDE DECREASED | 1 0.01 12.25 BLOOD CHLORIDE INCREASED | 1 0.01 12.26 BLOOD CHOLESTEROL DECREASED | 1 0.01 12.27 BLOOD CHOLESTEROL INCREASED | 37 0.37 12.64 BLOOD CREATINE PHOSPHOKINASE INCREASED | 12 0.12 12.76 BLOOD CREATINE PHOSPHOKINASE MB INCRE.. | 1 0.01 12.77 BLOOD CREATININE | 2 0.02 12.79 BLOOD CREATININE ABNORMAL | 1 0.01 12.80 BLOOD CREATININE DECREASED | 1 0.01 12.81 BLOOD CREATININE INCREASED | 18 0.18 12.99 BLOOD CULTURE POSITIVE | 2 0.02 13.01 BLOOD DISORDER | 1 0.01 13.02 BLOOD ELECTROLYTES ABNORMAL | 1 0.01 13.03 BLOOD GLUCOSE ABNORMAL | 1 0.01 13.04 BLOOD GLUCOSE DECREASED | 4 0.04 13.08 BLOOD GLUCOSE FLUCTUATION | 1 0.01 13.09 BLOOD GLUCOSE INCREASED | 20 0.20 13.29 BLOOD HIV RNA INCREASED | 1 0.01 13.30 BLOOD IRON DECREASED | 1 0.01 13.31 BLOOD IRON INCREASED | 1 0.01 13.32 BLOOD LACTATE DEHYDROGENASE INCREASED | 15 0.15 13.47 BLOOD LACTIC ACID INCREASED | 2 0.02 13.49 BLOOD MAGNESIUM ABNORMAL | 1 0.01 13.50 BLOOD METHAEMOGLOBIN PRESENT | 1 0.01 13.51 BLOOD OSMOLARITY | 1 0.01 13.52 BLOOD PH DECREASED | 2 0.02 13.54 BLOOD PHOSPHORUS DECREASED | 1 0.01 13.55 BLOOD PHOSPHORUS INCREASED | 1 0.01 13.56 BLOOD POTASSIUM | 1 0.01 13.57 BLOOD POTASSIUM DECREASED | 8 0.08 13.65 BLOOD POTASSIUM INCREASED | 5 0.05 13.70 BLOOD PRESSURE ABNORMAL | 3 0.03 13.73 BLOOD PRESSURE DECREASED | 19 0.19 13.92 BLOOD PRESSURE DIASTOLIC DECREASED | 2 0.02 13.94 BLOOD PRESSURE FLUCTUATION | 5 0.05 13.99 BLOOD PRESSURE IMMEASURABLE | 2 0.02 14.01 BLOOD PRESSURE INADEQUATELY CONTROLLED | 3 0.03 14.04 BLOOD PRESSURE INCREASED | 26 0.26 14.30 BLOOD PRESSURE SYSTOLIC INCREASED | 4 0.04 14.34 BLOOD SODIUM DECREASED | 2 0.02 14.36 BLOOD SODIUM INCREASED | 3 0.03 14.39 BLOOD TEST ABNORMAL | 2 0.02 14.41 BLOOD TESTOSTERONE DECREASED | 1 0.01 14.42 BLOOD THYROID STIMULATING HORMONE DEC.. | 1 0.01 14.43 BLOOD TRIGLYCERIDES INCREASED | 8 0.08 14.51 BLOOD UREA INCREASED | 15 0.15 14.66 BLOOD UREA NITROGEN/CREATININE RATIO .. | 1 0.01 14.67 BLOOD URIC ACID INCREASED | 1 0.01 14.68 BLOOD URINE PRESENT | 2 0.02 14.70 BODY DYSMORPHIC DISORDER | 1 0.01 14.71 BODY HEIGHT DECREASED | 1 0.01 14.72 BODY TEMPERATURE DECREASED | 2 0.02 14.74 BODY TEMPERATURE INCREASED | 7 0.07 14.81 BODY TINEA | 1 0.01 14.82 BONE DISORDER | 6 0.06 14.88 BONE GRAFT | 1 0.01 14.89 BONE MARROW DISORDER | 1 0.01 14.90 BONE MARROW FAILURE | 10 0.10 15.00 BONE MARROW MYELOGRAM ABNORMAL | 1 0.01 15.01 BONE MARROW TRANSPLANT | 1 0.01 15.02 BONE PAIN | 5 0.05 15.07 BONE TUBERCULOSIS | 1 0.01 15.08 BORRELIA INFECTION | 1 0.01 15.09 BOWEL SOUNDS ABNORMAL | 1 0.01 15.10 BOWEN'S DISEASE | 1 0.01 15.11 BRADYCARDIA | 19 0.19 15.30 BRAIN CONTUSION | 1 0.01 15.31 BRAIN DEATH | 2 0.02 15.33 BRAIN NEOPLASM | 1 0.01 15.34 BRAIN OEDEMA | 4 0.04 15.38 BRAIN STEM HAEMORRHAGE | 1 0.01 15.39 BRAIN STEM INFARCTION | 3 0.03 15.42 BRAIN STEM SYNDROME | 1 0.01 15.43 BREAST CANCER | 4 0.04 15.47 BREAST CANCER FEMALE | 17 0.17 15.64 BREAST CANCER IN SITU | 4 0.04 15.68 BREAST CANCER RECURRENT | 1 0.01 15.69 BREAST CANCER STAGE III | 1 0.01 15.70 BREAST MASS | 1 0.01 15.71 BREAST PAIN | 1 0.01 15.72 BREATH SOUNDS ABNORMAL | 1 0.01 15.73 BRONCHIAL HYPERACTIVITY | 2 0.02 15.75 BRONCHIAL OBSTRUCTION | 1 0.01 15.76 BRONCHIECTASIS | 1 0.01 15.77 BRONCHIOLOALVEOLAR CARCINOMA | 1 0.01 15.78 BRONCHITIS | 16 0.16 15.94 BRONCHITIS ACUTE | 3 0.03 15.97 BRONCHITIS BACTERIAL | 1 0.01 15.98 BRONCHITIS CHRONIC | 3 0.03 16.01 BRONCHOPNEUMONIA | 1 0.01 16.02 BRONCHOSCOPY ABNORMAL | 1 0.01 16.03 BRONCHOSPASM | 4 0.04 16.07 BRUXISM | 1 0.01 16.08 BUNDLE BRANCH BLOCK | 1 0.01 16.09 BUNDLE BRANCH BLOCK LEFT | 4 0.04 16.13 BUNDLE BRANCH BLOCK RIGHT | 6 0.06 16.19 BUNION | 2 0.02 16.21 BURKITT'S LYMPHOMA | 1 0.01 16.22 BURNING SENSATION | 6 0.06 16.28 BURNS THIRD DEGREE | 1 0.01 16.29 BURSITIS | 1 0.01 16.30 C-REACTIVE PROTEIN INCREASED | 8 0.08 16.38 CAESAREAN SECTION | 5 0.05 16.43 CALCIFICATION OF MUSCLE | 1 0.01 16.44 CALCINOSIS | 1 0.01 16.45 CALCIPHYLAXIS | 1 0.01 16.46 CALCULUS URETERIC | 1 0.01 16.47 CALCULUS URETHRAL | 1 0.01 16.48 CANDIDIASIS | 2 0.02 16.50 CARBOHYDRATE ANTIGEN 19-9 INCREASED | 1 0.01 16.51 CARBON DIOXIDE DECREASED | 2 0.02 16.53 CARCINOID TUMOUR | 1 0.01 16.54 CARDIAC ABLATION | 1 0.01 16.55 CARDIAC ARREST | 23 0.23 16.78 CARDIAC DISORDER | 55 0.55 17.33 CARDIAC ENZYMES INCREASED | 1 0.01 17.34 CARDIAC FAILURE | 25 0.25 17.59 CARDIAC FAILURE ACUTE | 4 0.04 17.63 CARDIAC FAILURE CHRONIC | 2 0.02 17.65 CARDIAC FAILURE CONGESTIVE | 52 0.52 18.17 CARDIAC FUNCTION DISTURBANCE POSTOPER.. | 1 0.01 18.18 CARDIAC INFECTION | 1 0.01 18.19 CARDIAC MURMUR | 8 0.08 18.27 CARDIAC OPERATION | 3 0.03 18.30 CARDIAC STRESS TEST ABNORMAL | 1 0.01 18.31 CARDIAC TAMPONADE | 2 0.02 18.33 CARDIAC VALVE DISEASE | 5 0.05 18.38 CARDIO-RESPIRATORY ARREST | 14 0.14 18.52 CARDIOGENIC SHOCK | 6 0.06 18.58 CARDIOMEGALY | 9 0.09 18.67 CARDIOMYOPATHY | 6 0.06 18.73 CARDIOPULMONARY FAILURE | 1 0.01 18.74 CARDIOVASCULAR DISORDER | 58 0.58 19.32 CAROTID ARTERY DISEASE | 1 0.01 19.33 CAROTID ARTERY OCCLUSION | 3 0.03 19.36 CAROTID ARTERY STENOSIS | 13 0.13 19.49 CAROTID BRUIT | 1 0.01 19.50 CARPAL TUNNEL SYNDROME | 6 0.06 19.56 CARTILAGE INJURY | 1 0.01 19.57 CATARACT | 11 0.11 19.68 CATARACT CONGENITAL | 1 0.01 19.69 CATARACT OPERATION | 2 0.02 19.71 CATARACT OPERATION COMPLICATION | 1 0.01 19.72 CATHETER RELATED INFECTION | 3 0.03 19.75 CATHETER SEPSIS | 3 0.03 19.78 CATHETER SITE DISCHARGE | 1 0.01 19.79 CATHETER SITE HAEMORRHAGE | 1 0.01 19.80 CATHETER SITE RELATED REACTION | 1 0.01 19.81 CAUSTIC INJURY | 1 0.01 19.82 CD4 LYMPHOCYTES DECREASED | 1 0.01 19.83 CELLULITIS | 18 0.18 20.01 CELLULITIS STAPHYLOCOCCAL | 1 0.01 20.02 CENTRAL LINE INFECTION | 2 0.02 20.04 CEPHALHAEMATOMA | 1 0.01 20.05 CEREBELLAR ATROPHY | 1 0.01 20.06 CEREBELLAR INFARCTION | 2 0.02 20.08 CEREBRAL ARTERIOSCLEROSIS | 1 0.01 20.09 CEREBRAL ARTERY OCCLUSION | 2 0.02 20.11 CEREBRAL ATROPHY | 3 0.03 20.14 CEREBRAL CIRCULATORY FAILURE | 1 0.01 20.15 CEREBRAL HAEMATOMA | 1 0.01 20.16 CEREBRAL HAEMORRHAGE | 8 0.08 20.24 CEREBRAL INFARCTION | 10 0.10 20.34 CEREBRAL ISCHAEMIA | 4 0.04 20.38 CEREBROVASCULAR ACCIDENT | 151 1.51 21.89 CEREBROVASCULAR DISORDER | 2 0.02 21.91 CERUMEN IMPACTION | 2 0.02 21.93 CERVICAL POLYP | 1 0.01 21.94 CERVICITIS HUMAN PAPILLOMA VIRUS | 1 0.01 21.95 CERVICOBRACHIAL SYNDROME | 1 0.01 21.96 CERVIX CARCINOMA | 1 0.01 21.97 CHAPPED LIPS | 1 0.01 21.98 CHEILITIS | 4 0.04 22.02 CHEST DISCOMFORT | 16 0.16 22.18 CHEST PAIN | 98 0.98 23.16 CHEST X-RAY ABNORMAL | 4 0.04 23.20 CHILLS | 21 0.21 23.41 CHLAMYDIAL INFECTION | 1 0.01 23.42 CHOKING | 1 0.01 23.43 CHOLANGIOLITIS | 1 0.01 23.44 CHOLANGITIS | 6 0.06 23.50 CHOLECYSTECTOMY | 2 0.02 23.52 CHOLECYSTITIS | 4 0.04 23.56 CHOLECYSTITIS CHRONIC | 2 0.02 23.58 CHOLELITHIASIS | 15 0.15 23.73 CHOLESTASIS | 4 0.04 23.77 CHOLURIA | 1 0.01 23.78 CHOREOATHETOSIS | 1 0.01 23.79 CHOROIDAL RUPTURE | 1 0.01 23.80 CHROMATURIA | 13 0.13 23.93 CHROMOSOME ABNORMALITY | 1 0.01 23.94 CHRONIC INFLAMMATORY DEMYELINATING PO.. | 1 0.01 23.95 CHRONIC LYMPHOCYTIC LEUKAEMIA | 3 0.03 23.98 CHRONIC MYELOID LEUKAEMIA | 1 0.01 23.99 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 27 0.27 24.26 CHRONIC SINUSITIS | 1 0.01 24.27 CIRCULATORY COLLAPSE | 7 0.07 24.34 CIRCUMSTANCE OR INFORMATION CAPABLE O.. | 3 0.03 24.37 CLOSTRIDIAL INFECTION | 7 0.07 24.44 CLOSTRIDIUM COLITIS | 5 0.05 24.49 CLUMSINESS | 1 0.01 24.50 COAGULATION FACTOR V LEVEL DECREASED | 1 0.01 24.51 COAGULATION FACTOR VII LEVEL DECREASED | 1 0.01 24.52 COAGULATION FACTOR X LEVEL DECREASED | 2 0.02 24.54 COAGULATION TIME PROLONGED | 1 0.01 24.55 COAGULOPATHY | 8 0.08 24.63 COGNITIVE DETERIORATION | 2 0.02 24.65 COGNITIVE DISORDER | 2 0.02 24.67 COLD SWEAT | 4 0.04 24.71 COLITIS | 14 0.14 24.85 COLITIS COLLAGENOUS | 1 0.01 24.86 COLITIS ISCHAEMIC | 2 0.02 24.88 COLITIS ULCERATIVE | 8 0.08 24.96 COLLAGEN DISORDER | 1 0.01 24.97 COLLAPSE OF LUNG | 2 0.02 24.99 COLON ADENOMA | 1 0.01 25.00 COLON CANCER | 2 0.02 25.02 COLON CANCER METASTATIC | 2 0.02 25.04 COLON NEOPLASM | 1 0.01 25.05 COLONIC POLYP | 5 0.05 25.10 COLONOSCOPY | 1 0.01 25.11 COLOUR BLINDNESS | 1 0.01 25.12 COMA | 14 0.14 25.26 COMA HEPATIC | 1 0.01 25.27 COMPLETED SUICIDE | 21 0.21 25.48 COMPLEX PARTIAL SEIZURES | 1 0.01 25.49 COMPLICATIONS OF TRANSPLANT SURGERY | 2 0.02 25.51 COMPUTERISED TOMOGRAM ABNORMAL | 1 0.01 25.52 CONCOMITANT DISEASE AGGRAVATED | 1 0.01 25.53 CONCOMITANT DISEASE PROGRESSION | 2 0.02 25.55 CONCUSSION | 1 0.01 25.56 CONDITION AGGRAVATED | 38 0.38 25.94 CONDUCTION DISORDER | 1 0.01 25.95 CONDYLOMA ACUMINATUM | 1 0.01 25.96 CONFUSIONAL STATE | 36 0.36 26.32 CONGENITAL ANOMALY | 3 0.03 26.35 CONGENITAL CENTRAL NERVOUS SYSTEM ANO.. | 1 0.01 26.36 CONGENITAL CYSTIC KIDNEY DISEASE | 3 0.03 26.39 CONGENITAL DIAPHRAGMATIC HERNIA | 1 0.01 26.40 CONGENITAL EYELID MALFORMATION | 1 0.01 26.41 CONGENITAL HAND MALFORMATION | 1 0.01 26.42 CONGENITAL HYDROCEPHALUS | 1 0.01 26.43 CONGENITAL HYDRONEPHROSIS | 1 0.01 26.44 CONGENITAL MULTIPLEX ARTHROGRYPOSIS | 1 0.01 26.45 CONGENITAL MUSCLE ABSENCE | 1 0.01 26.46 CONJUNCTIVAL HYPERAEMIA | 4 0.04 26.50 CONJUNCTIVITIS | 5 0.05 26.55 CONJUNCTIVITIS VIRAL | 1 0.01 26.56 CONNECTIVE TISSUE DISORDER | 1 0.01 26.57 CONSTIPATION | 19 0.19 26.76 CONTUSION | 13 0.13 26.89 CONVERSION DISORDER | 1 0.01 26.90 CONVULSION | 31 0.31 27.21 COOMBS POSITIVE HAEMOLYTIC ANAEMIA | 1 0.01 27.22 COORDINATION ABNORMAL | 6 0.06 27.28 COR PULMONALE | 1 0.01 27.29 CORONARY ARTERY DISEASE | 79 0.79 28.08 CORONARY ARTERY OCCLUSION | 17 0.17 28.25 CORONARY ARTERY RESTENOSIS | 3 0.03 28.28 CORONARY ARTERY STENOSIS | 18 0.18 28.46 CORONARY ARTERY SURGERY | 1 0.01 28.47 CORONARY ARTERY THROMBOSIS | 3 0.03 28.50 CORONARY OSTIAL STENOSIS | 1 0.01 28.51 COSTOCHONDRITIS | 1 0.01 28.52 COUGH | 23 0.23 28.75 CREATININE RENAL CLEARANCE INCREASED | 1 0.01 28.76 CREPITATIONS | 2 0.02 28.78 CREUTZFELDT-JAKOB DISEASE | 1 0.01 28.79 CROHN'S DISEASE | 10 0.10 28.89 CROUP INFECTIOUS | 1 0.01 28.90 CRYING | 13 0.13 29.03 CRYPTOCOCCOSIS | 1 0.01 29.04 CRYPTOGENIC ORGANIZING PNEUMONIA | 1 0.01 29.05 CRYPTORCHISM | 1 0.01 29.06 CSF CELL COUNT INCREASED | 1 0.01 29.07 CSF PRESSURE INCREASED | 1 0.01 29.08 CSF PROTEIN ABNORMAL | 1 0.01 29.09 CSF PROTEIN INCREASED | 1 0.01 29.10 CSF TEST ABNORMAL | 1 0.01 29.11 CULTURE URINE | 1 0.01 29.12 CULTURE WOUND POSITIVE | 1 0.01 29.13 CUTANEOUS TUBERCULOSIS | 1 0.01 29.14 CUTANEOUS VASCULITIS | 1 0.01 29.15 CYANOPSIA | 1 0.01 29.16 CYANOSIS | 5 0.05 29.21 CYANOSIS CENTRAL | 1 0.01 29.22 CYST | 5 0.05 29.27 CYSTITIS | 6 0.06 29.33 CYSTITIS HAEMORRHAGIC | 1 0.01 29.34 CYSTITIS NONINFECTIVE | 2 0.02 29.36 CYTOMEGALOVIRUS INFECTION | 6 0.06 29.42 DEAFNESS | 6 0.06 29.48 DEAFNESS NEUROSENSORY | 1 0.01 29.49 DEAFNESS UNILATERAL | 2 0.02 29.51 DEATH | 71 0.71 30.22 DEATH NEONATAL | 1 0.01 30.23 DECREASED ACTIVITY | 2 0.02 30.25 DECREASED APPETITE | 11 0.11 30.36 DECUBITUS ULCER | 1 0.01 30.37 DEEP VEIN THROMBOSIS | 31 0.31 30.68 DEHYDRATION | 44 0.44 31.12 DELAYED RECOVERY FROM ANAESTHESIA | 1 0.01 31.13 DELIRIUM | 8 0.08 31.21 DELIRIUM TREMENS | 1 0.01 31.22 DELUSION | 4 0.04 31.26 DELUSIONAL DISORDER, UNSPECIFIED TYPE | 1 0.01 31.27 DEMENTIA | 11 0.11 31.38 DEMENTIA ALZHEIMER'S TYPE | 3 0.03 31.41 DEMYELINATION | 1 0.01 31.42 DENTAL CARIES | 1 0.01 31.43 DENTAL DISCOMFORT | 1 0.01 31.44 DENTAL OPERATION | 1 0.01 31.45 DEPENDENCE | 1 0.01 31.46 DEPRESSED LEVEL OF CONSCIOUSNESS | 16 0.16 31.62 DEPRESSED MOOD | 1 0.01 31.63 DEPRESSION | 94 0.94 32.57 DEPRESSION SUICIDAL | 1 0.01 32.58 DERMAL CYST | 1 0.01 32.59 DERMATITIS | 2 0.02 32.61 DERMATITIS BULLOUS | 5 0.05 32.66 DERMATITIS CONTACT | 1 0.01 32.67 DERMATITIS EXFOLIATIVE | 4 0.04 32.71 DERMATITIS PSORIASIFORM | 2 0.02 32.73 DEVICE FAILURE | 4 0.04 32.77 DEVICE INEFFECTIVE | 1 0.01 32.78 DEVICE RELATED INFECTION | 1 0.01 32.79 DIABETES MELLITUS | 24 0.24 33.03 DIABETES MELLITUS INADEQUATE CONTROL | 6 0.06 33.09 DIABETES MELLITUS INSULIN-DEPENDENT | 3 0.03 33.12 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 14 0.14 33.26 DIABETIC BLINDNESS | 1 0.01 33.27 DIABETIC COMPLICATION | 2 0.02 33.29 DIABETIC EYE DISEASE | 1 0.01 33.30 DIABETIC FOOT | 1 0.01 33.31 DIABETIC HYPEROSMOLAR COMA | 1 0.01 33.32 DIABETIC KETOACIDOSIS | 6 0.06 33.38 DIABETIC RETINOPATHY | 2 0.02 33.40 DIABETIC ULCER | 1 0.01 33.41 DIALYSIS | 5 0.05 33.46 DIAPHRAGMATIC DISORDER | 1 0.01 33.47 DIARRHOEA | 49 0.49 33.96 DIARRHOEA HAEMORRHAGIC | 2 0.02 33.98 DIASTOLIC DYSFUNCTION | 1 0.01 33.99 DIFFICULTY IN WALKING | 10 0.10 34.09 DIFFUSE LARGE B-CELL LYMPHOMA | 1 0.01 34.10 DILATATION ATRIAL | 4 0.04 34.14 DILATATION VENTRICULAR | 2 0.02 34.16 DIPLOPIA | 7 0.07 34.23 DISABILITY | 1 0.01 34.24 DISEASE PROGRESSION | 10 0.10 34.34 DISEASE RECURRENCE | 5 0.05 34.39 DISLOCATION OF JOINT PROSTHESIS | 1 0.01 34.40 DISLOCATION OF VERTEBRA | 1 0.01 34.41 DISORIENTATION | 13 0.13 34.54 DISSEMINATED INTRAVASCULAR COAGULATION | 9 0.09 34.63 DISSOCIATION | 2 0.02 34.65 DISTURBANCE IN ATTENTION | 11 0.11 34.76 DIVERTICULITIS | 8 0.08 34.84 DIVERTICULUM | 5 0.05 34.89 DIVERTICULUM INTESTINAL | 1 0.01 34.90 DIZZINESS | 72 0.72 35.62 DIZZINESS POSTURAL | 2 0.02 35.64 DOUGLAS' POUCH MASS | 1 0.01 35.65 DROOLING | 1 0.01 35.66 DROWNING | 1 0.01 35.67 DRUG ABUSER | 10 0.10 35.77 DRUG ADMINISTRATION ERROR | 7 0.07 35.84 DRUG DEPENDENCE | 5 0.05 35.89 DRUG DISPENSING ERROR | 23 0.23 36.12 DRUG DOSE OMISSION | 1 0.01 36.13 DRUG EFFECT DECREASED | 4 0.04 36.17 DRUG ERUPTION | 6 0.06 36.23 DRUG EXPOSURE BEFORE PREGNANCY | 1 0.01 36.24 DRUG EXPOSURE DURING PREGNANCY | 51 0.51 36.75 DRUG EXPOSURE VIA BREAST MILK | 3 0.03 36.78 DRUG HYPERSENSITIVITY | 14 0.14 36.92 DRUG INEFFECTIVE | 70 0.70 37.62 DRUG INTERACTION | 38 0.38 38.00 DRUG INTERACTION POTENTIATION | 1 0.01 38.01 DRUG INTOLERANCE | 2 0.02 38.03 DRUG LEVEL DECREASED | 2 0.02 38.05 DRUG LEVEL INCREASED | 5 0.05 38.10 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 1 0.01 38.11 DRUG RESISTANCE | 1 0.01 38.12 DRUG SCREEN FALSE POSITIVE | 3 0.03 38.15 DRUG SCREEN POSITIVE | 5 0.05 38.20 DRUG TOLERANCE | 1 0.01 38.21 DRUG TOXICITY | 20 0.20 38.41 DRUG WITHDRAWAL SYNDROME | 19 0.19 38.60 DRUG WITHDRAWAL SYNDROME NEONATAL | 4 0.04 38.64 DRY EYE | 4 0.04 38.68 DRY MOUTH | 7 0.07 38.75 DRY SKIN | 9 0.09 38.84 DRY THROAT | 1 0.01 38.85 DUODENAL ULCER | 2 0.02 38.87 DUODENAL ULCER HAEMORRHAGE | 1 0.01 38.88 DUODENITIS | 4 0.04 38.92 DYSAESTHESIA | 2 0.02 38.94 DYSARTHRIA | 15 0.15 39.09 DYSGEUSIA | 4 0.04 39.13 DYSKINESIA | 10 0.10 39.23 DYSLIPIDAEMIA | 3 0.03 39.26 DYSPEPSIA | 16 0.16 39.42 DYSPHAGIA | 19 0.19 39.61 DYSPHASIA | 2 0.02 39.63 DYSPHONIA | 2 0.02 39.65 DYSPHORIA | 2 0.02 39.67 DYSPLASIA | 2 0.02 39.69 DYSPNOEA | 78 0.78 40.47 DYSPNOEA EXACERBATED | 2 0.02 40.49 DYSPNOEA EXERTIONAL | 8 0.08 40.57 DYSSTASIA | 6 0.06 40.63 DYSTONIA | 5 0.05 40.68 DYSURIA | 7 0.07 40.75 EAR CANAL INJURY | 1 0.01 40.76 EAR DEFORMITY ACQUIRED | 1 0.01 40.77 EAR DISORDER | 1 0.01 40.78 EAR INFECTION | 1 0.01 40.79 EAR MALFORMATION | 1 0.01 40.80 EAR PAIN | 3 0.03 40.83 EATING DISORDER | 3 0.03 40.86 ECCHYMOSIS | 3 0.03 40.89 ECONOMIC PROBLEM | 1 0.01 40.90 ECTOPIC PREGNANCY | 1 0.01 40.91 ECZEMA | 5 0.05 40.96 EFFUSION | 1 0.01 40.97 EJECTION FRACTION DECREASED | 2 0.02 40.99 ELDER ABUSE | 1 0.01 41.00 ELECTROCARDIOGRAM ABNORMAL | 3 0.03 41.03 ELECTROCARDIOGRAM Q WAVE ABNORMAL | 1 0.01 41.04 ELECTROCARDIOGRAM QT CORRECTED INTERV.. | 3 0.03 41.07 ELECTROCARDIOGRAM QT PROLONGED | 1 0.01 41.08 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION | 1 0.01 41.09 ELECTROCARDIOGRAM ST SEGMENT ELEVATION | 2 0.02 41.11 ELECTROCARDIOGRAM ST-T CHANGE | 1 0.01 41.12 ELECTROCARDIOGRAM T WAVE ABNORMAL | 1 0.01 41.13 ELECTROCARDIOGRAM T WAVE INVERSION | 1 0.01 41.14 ELECTROENCEPHALOGRAM ABNORMAL | 2 0.02 41.16 ELECTROLYTE IMBALANCE | 2 0.02 41.18 ELECTROLYTE SUBSTITUTION THERAPY | 1 0.01 41.19 EMBOLISM | 2 0.02 41.21 EMOTIONAL DISORDER | 2 0.02 41.23 EMOTIONAL DISTRESS | 8 0.08 41.31 EMPHYSEMA | 4 0.04 41.35 EMPYEMA | 1 0.01 41.36 ENCEPHALITIS | 1 0.01 41.37 ENCEPHALOPATHY | 9 0.09 41.46 ENDOCARDITIS | 1 0.01 41.47 ENDOLYMPHATIC HYDROPS | 1 0.01 41.48 ENTERITIS | 3 0.03 41.51 ENTEROCOCCAL INFECTION | 3 0.03 41.54 ENTEROCOLITIS | 2 0.02 41.56 EOSINOPHIL COUNT INCREASED | 4 0.04 41.60 EOSINOPHILIA | 9 0.09 41.69 EPICONDYLITIS | 1 0.01 41.70 EPIGASTRIC DISCOMFORT | 1 0.01 41.71 EPILEPSY | 4 0.04 41.75 EPISCLERITIS | 1 0.01 41.76 EPISTAXIS | 16 0.16 41.92 EPSTEIN-BARR VIRUS INFECTION | 1 0.01 41.93 ERECTILE DYSFUNCTION | 10 0.10 42.03 ERECTION INCREASED | 2 0.02 42.05 EROSIVE OESOPHAGITIS | 1 0.01 42.06 ERUCTATION | 3 0.03 42.09 ERYTHEMA | 16 0.16 42.25 ERYTHEMA MULTIFORME | 5 0.05 42.30 ERYTHEMA NODOSUM | 1 0.01 42.31 ESCHERICHIA INFECTION | 1 0.01 42.32 ESCHERICHIA SEPSIS | 2 0.02 42.34 ESCHERICHIA URINARY TRACT INFECTION | 1 0.01 42.35 ESSENTIAL HYPERTENSION | 3 0.03 42.38 EUPHORIC MOOD | 1 0.01 42.39 EXCORIATION | 1 0.01 42.40 EXERCISE ELECTROCARDIOGRAM ABNORMAL | 1 0.01 42.41 EXERCISE TOLERANCE DECREASED | 2 0.02 42.43 EXOSTOSIS | 2 0.02 42.45 EXTERNAL AUDITORY CANAL ATRESIA | 1 0.01 42.46 EXTRADURAL HAEMATOMA | 2 0.02 42.48 EXTRAPYRAMIDAL DISORDER | 4 0.04 42.52 EXTRASYSTOLES | 3 0.03 42.55 EYE ALLERGY | 1 0.01 42.56 EYE DISORDER | 5 0.05 42.61 EYE HAEMORRHAGE | 3 0.03 42.64 EYE INFECTION | 2 0.02 42.66 EYE IRRITATION | 5 0.05 42.71 EYE MOVEMENT DISORDER | 2 0.02 42.73 EYE OEDEMA | 2 0.02 42.75 EYE PAIN | 5 0.05 42.80 EYE PRURITUS | 3 0.03 42.83 EYE SWELLING | 2 0.02 42.85 EYELID DISORDER | 1 0.01 42.86 EYELID FUNCTION DISORDER | 1 0.01 42.87 EYELID OEDEMA | 2 0.02 42.89 EYELID PTOSIS | 1 0.01 42.90 FACE OEDEMA | 6 0.06 42.96 FACIAL BONES FRACTURE | 1 0.01 42.97 FACIAL DYSMORPHISM | 1 0.01 42.98 FACIAL PALSY | 4 0.04 43.02 FACIAL PARESIS | 1 0.01 43.03 FAECAL INCONTINENCE | 2 0.02 43.05 FAECALOMA | 1 0.01 43.06 FAECES DISCOLOURED | 4 0.04 43.10 FAILURE TO THRIVE | 1 0.01 43.11 FALL | 46 0.46 43.57 FAMILIAL TREMOR | 1 0.01 43.58 FATIGUE | 60 0.60 44.18 FEAR | 3 0.03 44.21 FEBRILE NEUTROPENIA | 7 0.07 44.28 FEEDING DISORDER | 2 0.02 44.30 FEEDING DISORDER NEONATAL | 2 0.02 44.32 FEEDING TUBE COMPLICATION | 1 0.01 44.33 FEELING ABNORMAL | 10 0.10 44.43 FEELING COLD | 2 0.02 44.45 FEELING DRUNK | 2 0.02 44.47 FEELING HOT | 4 0.04 44.51 FEELING JITTERY | 2 0.02 44.53 FEELINGS OF WORTHLESSNESS | 1 0.01 44.54 FEMORAL NECK FRACTURE | 3 0.03 44.57 FEMUR FRACTURE | 3 0.03 44.60 FIBROCYSTIC BREAST DISEASE | 1 0.01 44.61 FIBROMYALGIA | 2 0.02 44.63 FIBROSIS | 1 0.01 44.64 FIBROUS HISTIOCYTOMA | 1 0.01 44.65 FISTULA | 2 0.02 44.67 FLANK PAIN | 1 0.01 44.68 FLASHBACK | 1 0.01 44.69 FLATULENCE | 1 0.01 44.70 FLOPPY INFANT | 1 0.01 44.71 FLUID INTAKE REDUCED | 1 0.01 44.72 FLUID RETENTION | 7 0.07 44.79 FLUSHING | 4 0.04 44.83 FOAMING AT MOUTH | 1 0.01 44.84 FOCAL NODULAR HYPERPLASIA | 1 0.01 44.85 FOETAL DISTRESS SYNDROME | 1 0.01 44.86 FOETAL GROWTH RETARDATION | 1 0.01 44.87 FOETAL HEART RATE DECELERATION | 1 0.01 44.88 FOLLICULITIS | 2 0.02 44.90 FOOD INTERACTION | 1 0.01 44.91 FOOT DEFORMITY | 1 0.01 44.92 FOOT FRACTURE | 1 0.01 44.93 FORMICATION | 1 0.01 44.94 FRACTURE | 2 0.02 44.96 FREQUENT BOWEL MOVEMENTS | 1 0.01 44.97 FUNGAL INFECTION | 6 0.06 45.03 GAIT DISTURBANCE | 12 0.12 45.15 GALLBLADDER CANCER | 1 0.01 45.16 GALLBLADDER DISORDER | 5 0.05 45.21 GALLBLADDER POLYP | 1 0.01 45.22 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 14 0.14 45.36 GANGRENE | 1 0.01 45.37 GASTRIC CANCER | 1 0.01 45.38 GASTRIC DISORDER | 6 0.06 45.44 GASTRIC HAEMORRHAGE | 1 0.01 45.45 GASTRIC PERFORATION | 1 0.01 45.46 GASTRIC POLYPS | 1 0.01 45.47 GASTRIC ULCER | 7 0.07 45.54 GASTRIC ULCER HAEMORRHAGE | 3 0.03 45.57 GASTRITIS | 11 0.11 45.68 GASTRITIS EROSIVE | 1 0.01 45.69 GASTRITIS HAEMORRHAGIC | 1 0.01 45.70 GASTROENTERITIS | 3 0.03 45.73 GASTROENTERITIS STAPHYLOCOCCAL | 1 0.01 45.74 GASTROENTERITIS VIRAL | 3 0.03 45.77 GASTROINTESTINAL ANASTOMOTIC LEAK | 1 0.01 45.78 GASTROINTESTINAL CARCINOMA | 1 0.01 45.79 GASTROINTESTINAL DISORDER | 21 0.21 46.00 GASTROINTESTINAL DISORDER POSTOPERATIVE | 1 0.01 46.01 GASTROINTESTINAL HAEMORRHAGE | 23 0.23 46.24 GASTROINTESTINAL HYPOMOTILITY | 1 0.01 46.25 GASTROINTESTINAL INJURY | 1 0.01 46.26 GASTROINTESTINAL NECROSIS | 1 0.01 46.27 GASTROINTESTINAL NEOPLASM | 1 0.01 46.28 GASTROINTESTINAL OBSTRUCTION | 3 0.03 46.31 GASTROINTESTINAL PAIN | 1 0.01 46.32 GASTROINTESTINAL PERFORATION | 1 0.01 46.33 GASTROOESOPHAGEAL REFLUX DISEASE | 26 0.26 46.59 GASTROOESOPHAGITIS | 1 0.01 46.60 GENE MUTATION | 1 0.01 46.61 GENERAL NUTRITION DISORDER | 1 0.01 46.62 GENERAL PHYSICAL CONDITION | 1 0.01 46.63 GENERAL PHYSICAL HEALTH DETERIORATION | 12 0.12 46.75 GENERALISED ANXIETY DISORDER | 1 0.01 46.76 GENERALISED ERYTHEMA | 3 0.03 46.79 GENERALISED OEDEMA | 3 0.03 46.82 GENITAL BURNING SENSATION | 1 0.01 46.83 GENITAL PAIN MALE | 1 0.01 46.84 GENITAL ULCERATION | 2 0.02 46.86 GINGIVAL BLEEDING | 3 0.03 46.89 GINGIVAL PAIN | 1 0.01 46.90 GINGIVAL RECESSION | 1 0.01 46.91 GINGIVITIS | 2 0.02 46.93 GINGIVITIS ULCERATIVE | 1 0.01 46.94 GLARE | 1 0.01 46.95 GLAUCOMA | 6 0.06 47.01 GLOMERULONEPHRITIS | 1 0.01 47.02 GLOSSITIS | 1 0.01 47.03 GLOSSODYNIA | 3 0.03 47.06 GLUCOSE TOLERANCE IMPAIRED | 3 0.03 47.09 GLUCOSE URINE PRESENT | 2 0.02 47.11 GLYCOSYLATED HAEMOGLOBIN INCREASED | 2 0.02 47.13 GOITRE | 3 0.03 47.16 GOUT | 8 0.08 47.24 GOUTY ARTHRITIS | 1 0.01 47.25 GRAFT DYSFUNCTION | 1 0.01 47.26 GRAFT VERSUS HOST DISEASE | 4 0.04 47.30 GRAND MAL CONVULSION | 8 0.08 47.38 GRANULOCYTE COUNT DECREASED | 1 0.01 47.39 GRANULOCYTOPENIA | 1 0.01 47.40 GRANULOMA | 2 0.02 47.42 GRAVITATIONAL OEDEMA | 1 0.01 47.43 GROIN ABSCESS | 1 0.01 47.44 GROIN PAIN | 3 0.03 47.47 GUILLAIN-BARRE SYNDROME | 2 0.02 47.49 GUN SHOT WOUND | 1 0.01 47.50 HAEMANGIOMA OF LIVER | 1 0.01 47.51 HAEMARTHROSIS | 1 0.01 47.52 HAEMATEMESIS | 8 0.08 47.60 HAEMATOCHEZIA | 9 0.09 47.69 HAEMATOCRIT DECREASED | 14 0.14 47.83 HAEMATOMA | 6 0.06 47.89 HAEMATOTOXICITY | 1 0.01 47.90 HAEMATURIA | 6 0.06 47.96 HAEMOCHROMATOSIS | 1 0.01 47.97 HAEMODIALYSIS | 7 0.07 48.04 HAEMODYNAMIC INSTABILITY | 1 0.01 48.05 HAEMOGLOBIN | 1 0.01 48.06 HAEMOGLOBIN DECREASED | 24 0.24 48.30 HAEMOLYSIS | 3 0.03 48.33 HAEMOLYTIC ANAEMIA | 2 0.02 48.35 HAEMOLYTIC URAEMIC SYNDROME | 2 0.02 48.37 HAEMOPTYSIS | 11 0.11 48.48 HAEMORRHAGE | 14 0.14 48.62 HAEMORRHAGE INTRACRANIAL | 1 0.01 48.63 HAEMORRHAGE SUBCUTANEOUS | 1 0.01 48.64 HAEMORRHAGIC DIATHESIS | 1 0.01 48.65 HAEMORRHAGIC TRANSFORMATION STROKE | 1 0.01 48.66 HAEMORRHOID OPERATION | 1 0.01 48.67 HAEMORRHOIDS | 7 0.07 48.74 HAEMOTHORAX | 2 0.02 48.76 HALLUCINATION | 14 0.14 48.90 HALLUCINATION, AUDITORY | 5 0.05 48.95 HALLUCINATION, VISUAL | 4 0.04 48.99 HALO VISION | 1 0.01 49.00 HAND DEFORMITY | 2 0.02 49.02 HAPTOGLOBIN DECREASED | 2 0.02 49.04 HEAD BANGING | 1 0.01 49.05 HEAD DISCOMFORT | 1 0.01 49.06 HEAD INJURY | 5 0.05 49.11 HEADACHE | 56 0.56 49.67 HEARING IMPAIRED | 4 0.04 49.71 HEART DISEASE CONGENITAL | 2 0.02 49.73 HEART INJURY | 2 0.02 49.75 HEART RATE ABNORMAL | 3 0.03 49.78 HEART RATE DECREASED | 5 0.05 49.83 HEART RATE INCREASED | 19 0.19 50.02 HEART RATE IRREGULAR | 13 0.13 50.15 HEART TRANSPLANT | 1 0.01 50.16 HEART TRANSPLANT REJECTION | 1 0.01 50.17 HEAT EXHAUSTION | 1 0.01 50.18 HELICOBACTER GASTRITIS | 1 0.01 50.19 HELICOBACTER PYLORI IDENTIFICATION TEST | 1 0.01 50.20 HEMIANOPIA | 1 0.01 50.21 HEMIPARESIS | 2 0.02 50.23 HEMIPLEGIA | 1 0.01 50.24 HEPATIC ADENOMA | 1 0.01 50.25 HEPATIC CIRRHOSIS | 11 0.11 50.36 HEPATIC CYST | 1 0.01 50.37 HEPATIC ENCEPHALOPATHY | 2 0.02 50.39 HEPATIC ENZYME ABNORMAL | 3 0.03 50.42 HEPATIC ENZYME INCREASED | 15 0.15 50.57 HEPATIC FAILURE | 11 0.11 50.68 HEPATIC FIBROSIS | 2 0.02 50.70 HEPATIC FUNCTION ABNORMAL | 16 0.16 50.86 HEPATIC MASS | 1 0.01 50.87 HEPATIC NEOPLASM | 1 0.01 50.88 HEPATIC NEOPLASM MALIGNANT | 1 0.01 50.89 HEPATIC STEATOSIS | 13 0.13 51.02 HEPATITIS | 7 0.07 51.09 HEPATITIS A | 1 0.01 51.10 HEPATITIS A ANTIBODY | 1 0.01 51.11 HEPATITIS ACUTE | 2 0.02 51.13 HEPATITIS C | 4 0.04 51.17 HEPATITIS C POSITIVE | 1 0.01 51.18 HEPATITIS CHOLESTATIC | 4 0.04 51.22 HEPATITIS FULMINANT | 1 0.01 51.23 HEPATOBILIARY NEOPLASM | 1 0.01 51.24 HEPATOCELLULAR DAMAGE | 34 0.34 51.58 HEPATOMEGALY | 3 0.03 51.61 HEPATOSPLENOMEGALY | 2 0.02 51.63 HEPATOTOXICITY | 5 0.05 51.68 HERNIA | 6 0.06 51.74 HERNIA REPAIR | 1 0.01 51.75 HERPES SIMPLEX | 4 0.04 51.79 HERPES VIRUS INFECTION | 2 0.02 51.81 HERPES ZOSTER | 5 0.05 51.86 HERPES ZOSTER OPHTHALMIC | 1 0.01 51.87 HIATUS HERNIA | 10 0.10 51.97 HIGH DENSITY LIPOPROTEIN DECREASED | 8 0.08 52.05 HIP ARTHROPLASTY | 1 0.01 52.06 HIP FRACTURE | 6 0.06 52.12 HIP SURGERY | 1 0.01 52.13 HIRSUTISM | 1 0.01 52.14 HISTIOCYTOSIS HAEMATOPHAGIC | 1 0.01 52.15 HIV INFECTION | 1 0.01 52.16 HOMICIDE | 2 0.02 52.18 HORDEOLUM | 2 0.02 52.20 HORMONE LEVEL ABNORMAL | 1 0.01 52.21 HOSPITALISATION | 3 0.03 52.24 HOT FLUSH | 8 0.08 52.32 HUMAN HERPES VIRUS 6 SEROLOGY POSITIVE | 1 0.01 52.33 HUMAN HERPESVIRUS 6 INFECTION | 1 0.01 52.34 HUNGER | 2 0.02 52.36 HYDROCEPHALUS | 1 0.01 52.37 HYDRONEPHROSIS | 4 0.04 52.41 HYDROPNEUMOTHORAX | 1 0.01 52.42 HYPERAMMONAEMIA | 1 0.01 52.43 HYPERBARIC OXYGEN THERAPY | 1 0.01 52.44 HYPERBILIRUBINAEMIA | 5 0.05 52.49 HYPERCALCAEMIA | 3 0.03 52.52 HYPERCAPNIA | 1 0.01 52.53 HYPERCHOLESTEROLAEMIA | 7 0.07 52.60 HYPERCREATININAEMIA | 1 0.01 52.61 HYPERGAMMAGLOBULINAEMIA | 1 0.01 52.62 HYPERGLYCAEMIA | 13 0.13 52.75 HYPERHIDROSIS | 25 0.25 53.00 HYPERKALAEMIA | 7 0.07 53.07 HYPERKERATOSIS | 1 0.01 53.08 HYPERLIPIDAEMIA | 24 0.24 53.32 HYPERMETABOLISM | 1 0.01 53.33 HYPERMOBILITY SYNDROME | 1 0.01 53.34 HYPERNATRAEMIA | 2 0.02 53.36 HYPEROSMOLAR STATE | 1 0.01 53.37 HYPERPARATHYROIDISM | 1 0.01 53.38 HYPERPHOSPHATAEMIA | 1 0.01 53.39 HYPERPLASIA | 1 0.01 53.40 HYPERREFLEXIA | 1 0.01 53.41 HYPERSENSITIVITY | 15 0.15 53.56 HYPERSOMNIA | 3 0.03 53.59 HYPERTENSION | 76 0.76 54.35 HYPERTENSIVE CARDIOMYOPATHY | 1 0.01 54.36 HYPERTENSIVE CRISIS | 4 0.04 54.40 HYPERTENSIVE EMERGENCY | 1 0.01 54.41 HYPERTENSIVE ENCEPHALOPATHY | 1 0.01 54.42 HYPERTENSIVE HEART DISEASE | 3 0.03 54.45 HYPERTHERMIA | 2 0.02 54.47 HYPERTHYROIDISM | 6 0.06 54.53 HYPERTONIA | 1 0.01 54.54 HYPERTRIGLYCERIDAEMIA | 4 0.04 54.58 HYPERTROPHIC CARDIOMYOPATHY | 1 0.01 54.59 HYPERTROPHY BREAST | 1 0.01 54.60 HYPERURICAEMIA | 2 0.02 54.62 HYPERVENTILATION | 3 0.03 54.65 HYPOAESTHESIA | 20 0.20 54.85 HYPOALBUMINAEMIA | 1 0.01 54.86 HYPOCALCAEMIA | 1 0.01 54.87 HYPOCOAGULABLE STATE | 1 0.01 54.88 HYPOGLYCAEMIA | 31 0.31 55.19 HYPOGLYCAEMIC COMA | 1 0.01 55.20 HYPOKALAEMIA | 9 0.09 55.29 HYPOKINESIA | 2 0.02 55.31 HYPOMANIA | 1 0.01 55.32 HYPONATRAEMIA | 12 0.12 55.44 HYPOPHOSPHATAEMIA | 2 0.02 55.46 HYPOPNOEA | 1 0.01 55.47 HYPOTENSION | 34 0.34 55.81 HYPOTHERMIA | 2 0.02 55.83 HYPOTHYROIDISM | 5 0.05 55.88 HYPOTONIA | 5 0.05 55.93 HYPOTONIA NEONATAL | 1 0.01 55.94 HYPOTRICHOSIS | 1 0.01 55.95 HYPOVENTILATION | 2 0.02 55.97 HYPOVOLAEMIA | 4 0.04 56.01 HYPOVOLAEMIC SHOCK | 1 0.01 56.02 HYPOXIA | 7 0.07 56.09 HYPOXIC ENCEPHALOPATHY | 3 0.03 56.12 HYSTERECTOMY | 4 0.04 56.16 IATROGENIC INJURY | 2 0.02 56.18 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 2 0.02 56.20 ILEAL PERFORATION | 1 0.01 56.21 ILEITIS | 2 0.02 56.23 ILEUS | 5 0.05 56.28 ILEUS PARALYTIC | 2 0.02 56.30 ILIAC ARTERY OCCLUSION | 1 0.01 56.31 ILL-DEFINED DISORDER | 3 0.03 56.34 IMMUNE RECONSTITUTION SYNDROME | 4 0.04 56.38 IMMUNE SYSTEM DISORDER | 2 0.02 56.40 IMMUNOGLOBULINS ABNORMAL | 1 0.01 56.41 IMPAIRED DRIVING ABILITY | 3 0.03 56.44 IMPAIRED GASTRIC EMPTYING | 1 0.01 56.45 IMPAIRED HEALING | 2 0.02 56.47 IMPAIRED SELF-CARE | 1 0.01 56.48 IMPAIRED WORK ABILITY | 5 0.05 56.53 IMPETIGO | 1 0.01 56.54 IMPLANT SITE ERYTHEMA | 1 0.01 56.55 IMPLANT SITE HAEMATOMA | 1 0.01 56.56 IMPLANT SITE PAIN | 1 0.01 56.57 IMPLANT SITE THROMBOSIS | 1 0.01 56.58 IMPRISONMENT | 1 0.01 56.59 IMPULSIVE BEHAVIOUR | 1 0.01 56.60 INADEQUATE ANALGESIA | 3 0.03 56.63 INADEQUATE DIET | 1 0.01 56.64 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 2 0.02 56.66 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 4 0.04 56.70 INCISION SITE COMPLICATION | 1 0.01 56.71 INCISIONAL HERNIA | 1 0.01 56.72 INCOHERENT | 3 0.03 56.75 INCONTINENCE | 4 0.04 56.79 INCORRECT DOSE ADMINISTERED | 6 0.06 56.85 INCORRECT ROUTE OF DRUG ADMINISTRATION | 2 0.02 56.87 INCREASED APPETITE | 1 0.01 56.88 INCREASED UPPER AIRWAY SECRETION | 2 0.02 56.90 INDURATION | 1 0.01 56.91 INFECTION | 15 0.15 57.06 INFECTION PARASITIC | 1 0.01 57.07 INFLAMMATION | 5 0.05 57.12 INFLAMMATORY BOWEL DISEASE | 10 0.10 57.22 INFLUENZA | 8 0.08 57.30 INFLUENZA LIKE ILLNESS | 9 0.09 57.39 INFREQUENT BOWEL MOVEMENTS | 1 0.01 57.40 INFUSION RELATED REACTION | 12 0.12 57.52 INFUSION SITE ABSCESS | 1 0.01 57.53 INFUSION SITE ERYTHEMA | 1 0.01 57.54 INGROWING NAIL | 1 0.01 57.55 INGUINAL HERNIA | 1 0.01 57.56 INGUINAL HERNIA REPAIR | 1 0.01 57.57 INITIAL INSOMNIA | 1 0.01 57.58 INJECTION SITE ABSCESS | 1 0.01 57.59 INJECTION SITE BRUISING | 1 0.01 57.60 INJECTION SITE ERYTHEMA | 1 0.01 57.61 INJECTION SITE HAEMORRHAGE | 3 0.03 57.64 INJECTION SITE INDURATION | 1 0.01 57.65 INJECTION SITE NERVE DAMAGE | 1 0.01 57.66 INJECTION SITE NODULE | 1 0.01 57.67 INJECTION SITE PAIN | 1 0.01 57.68 INJECTION SITE PRURITUS | 1 0.01 57.69 INJECTION SITE REACTION | 2 0.02 57.71 INJECTION SITE SWELLING | 2 0.02 57.73 INJURY | 20 0.20 57.93 INNER EAR DISORDER | 1 0.01 57.94 INSOMNIA | 47 0.47 58.41 INSULIN-REQUIRING TYPE II DIABETES ME.. | 1 0.01 58.42 INTENTIONAL DRUG MISUSE | 2 0.02 58.44 INTENTIONAL OVERDOSE | 13 0.13 58.57 INTENTIONAL SELF-INJURY | 4 0.04 58.61 INTERMITTENT CLAUDICATION | 1 0.01 58.62 INTERNAL INJURY | 1 0.01 58.63 INTERNATIONAL NORMALISED RATIO DECREA.. | 2 0.02 58.65 INTERNATIONAL NORMALISED RATIO INCREA.. | 18 0.18 58.83 INTERSTITIAL LUNG DISEASE | 14 0.14 58.97 INTERVERTEBRAL DISC DEGENERATION | 3 0.03 59.00 INTERVERTEBRAL DISC PROTRUSION | 10 0.10 59.10 INTERVERTEBRAL DISCITIS | 2 0.02 59.12 INTESTINAL FUNCTIONAL DISORDER | 4 0.04 59.16 INTESTINAL HAEMORRHAGE | 12 0.12 59.28 INTESTINAL ISCHAEMIA | 1 0.01 59.29 INTESTINAL OBSTRUCTION | 6 0.06 59.35 INTESTINAL PERFORATION | 2 0.02 59.37 INTESTINAL RESECTION | 1 0.01 59.38 INTESTINAL STENOSIS | 1 0.01 59.39 INTRA-UTERINE DEATH | 4 0.04 59.43 INTRACARDIAC THROMBUS | 3 0.03 59.46 INTRACRANIAL PRESSURE INCREASED | 2 0.02 59.48 INTRACRANIAL VENOUS SINUS THROMBOSIS | 1 0.01 59.49 INTRANEURAL CYST | 1 0.01 59.50 INTRAVENTRICULAR HAEMORRHAGE | 1 0.01 59.51 INTUBATION | 1 0.01 59.52 INVESTIGATION | 1 0.01 59.53 IRIS DISORDER | 1 0.01 59.54 IRITIS | 2 0.02 59.56 IRON BINDING CAPACITY TOTAL INCREASED | 1 0.01 59.57 IRON DEFICIENCY | 1 0.01 59.58 IRON DEFICIENCY ANAEMIA | 1 0.01 59.59 IRRITABILITY | 12 0.12 59.71 IRRITABLE BOWEL SYNDROME | 7 0.07 59.78 ISCHAEMIA | 1 0.01 59.79 ISCHAEMIC CARDIOMYOPATHY | 3 0.03 59.82 ISCHAEMIC HEPATITIS | 1 0.01 59.83 ISCHAEMIC STROKE | 10 0.10 59.93 JAUNDICE | 18 0.18 60.11 JAUNDICE CHOLESTATIC | 1 0.01 60.12 JAW DISORDER | 1 0.01 60.13 JC VIRUS INFECTION | 1 0.01 60.14 JOINT EFFUSION | 1 0.01 60.15 JOINT INJURY | 3 0.03 60.18 JOINT INSTABILITY | 1 0.01 60.19 JOINT RANGE OF MOTION DECREASED | 2 0.02 60.21 JOINT SPRAIN | 2 0.02 60.23 JOINT STIFFNESS | 2 0.02 60.25 JOINT SWELLING | 7 0.07 60.32 JUDGEMENT IMPAIRED | 1 0.01 60.33 KETOACIDOSIS | 1 0.01 60.34 KIDNEY FIBROSIS | 1 0.01 60.35 KIDNEY INFECTION | 3 0.03 60.38 KIDNEY TRANSPLANT REJECTION | 1 0.01 60.39 KLEBSIELLA INFECTION | 2 0.02 60.41 KNEE ARTHROPLASTY | 8 0.08 60.49 KORSAKOFF'S PSYCHOSIS NON-ALCOHOLIC | 2 0.02 60.51 LABORATORY TEST ABNORMAL | 4 0.04 60.55 LABOUR COMPLICATION | 1 0.01 60.56 LABYRINTHITIS | 2 0.02 60.58 LACERATION | 1 0.01 60.59 LACRIMATION DECREASED | 1 0.01 60.60 LACRIMATION INCREASED | 1 0.01 60.61 LACTIC ACIDOSIS | 6 0.06 60.67 LACUNAR INFARCTION | 5 0.05 60.72 LARGE INTESTINAL HAEMORRHAGE | 1 0.01 60.73 LARGE INTESTINAL OBSTRUCTION REDUCTION | 1 0.01 60.74 LARGE INTESTINAL ULCER | 1 0.01 60.75 LARGE INTESTINE PERFORATION | 1 0.01 60.76 LARYNGEAL OEDEMA | 7 0.07 60.83 LARYNGITIS | 1 0.01 60.84 LARYNGOSPASM | 1 0.01 60.85 LAZINESS | 1 0.01 60.86 LEFT VENTRICULAR FAILURE | 5 0.05 60.91 LEGIONELLA INFECTION | 1 0.01 60.92 LEIOMYOMA | 1 0.01 60.93 LENTIGO | 1 0.01 60.94 LETHARGY | 15 0.15 61.09 LEUKAEMIA | 2 0.02 61.11 LEUKOCYTOCLASTIC VASCULITIS | 4 0.04 61.15 LEUKOCYTOSIS | 2 0.02 61.17 LEUKOENCEPHALOPATHY | 2 0.02 61.19 LEUKOPENIA | 11 0.11 61.30 LHERMITTE'S SIGN | 1 0.01 61.31 LIBIDO DECREASED | 2 0.02 61.33 LIFE SUPPORT | 1 0.01 61.34 LIGAMENT DISORDER | 1 0.01 61.35 LIGAMENT SPRAIN | 1 0.01 61.36 LIMB CRUSHING INJURY | 1 0.01 61.37 LIMB DISCOMFORT | 3 0.03 61.40 LIMB INJURY | 4 0.04 61.44 LIP BLISTER | 1 0.01 61.45 LIP DRY | 2 0.02 61.47 LIP PAIN | 1 0.01 61.48 LIPASE INCREASED | 1 0.01 61.49 LIPOMA | 2 0.02 61.51 LISTERIOSIS | 1 0.01 61.52 LIVEDO RETICULARIS | 1 0.01 61.53 LIVER DISORDER | 35 0.35 61.88 LIVER FUNCTION TEST ABNORMAL | 14 0.14 62.02 LIVER TRANSPLANT | 2 0.02 62.04 LOCAL SWELLING | 2 0.02 62.06 LOCALISED INFECTION | 2 0.02 62.08 LOCALISED OEDEMA | 2 0.02 62.10 LOGORRHOEA | 1 0.01 62.11 LOSS OF CONSCIOUSNESS | 39 0.39 62.50 LOSS OF LIBIDO | 2 0.02 62.52 LOW DENSITY LIPOPROTEIN DECREASED | 1 0.01 62.53 LOW DENSITY LIPOPROTEIN INCREASED | 5 0.05 62.58 LOWER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 62.59 LOWER LIMB DEFORMITY | 1 0.01 62.60 LOWER LIMB FRACTURE | 4 0.04 62.64 LOWER RESPIRATORY TRACT INFECTION | 2 0.02 62.66 LUMBAR RADICULOPATHY | 1 0.01 62.67 LUMBAR SPINAL STENOSIS | 4 0.04 62.71 LUMBAR VERTEBRAL FRACTURE | 1 0.01 62.72 LUNG ADENOCARCINOMA | 1 0.01 62.73 LUNG CONSOLIDATION | 2 0.02 62.75 LUNG DISORDER | 10 0.10 62.85 LUNG INFECTION | 2 0.02 62.87 LUNG INFILTRATION | 2 0.02 62.89 LUNG NEOPLASM | 4 0.04 62.93 LUNG NEOPLASM MALIGNANT | 7 0.07 63.00 LUNG TRANSPLANT REJECTION | 1 0.01 63.01 LUPUS NEPHRITIS | 1 0.01 63.02 LYMPH NODE PAIN | 1 0.01 63.03 LYMPHADENITIS | 2 0.02 63.05 LYMPHADENOPATHY | 9 0.09 63.14 LYMPHADENOPATHY MEDIASTINAL | 1 0.01 63.15 LYMPHOCELE | 1 0.01 63.16 LYMPHOCYTE COUNT DECREASED | 2 0.02 63.18 LYMPHOCYTE MORPHOLOGY ABNORMAL | 1 0.01 63.19 LYMPHOCYTE STIMULATION TEST POSITIVE | 4 0.04 63.23 LYMPHOCYTOSIS | 1 0.01 63.24 LYMPHOEDEMA | 2 0.02 63.26 LYMPHOMA | 5 0.05 63.31 LYMPHOPROLIFERATIVE DISORDER | 2 0.02 63.33 MACULAR DEGENERATION | 2 0.02 63.35 MADAROSIS | 1 0.01 63.36 MAINTENANCE OF ANAESTHESIA | 1 0.01 63.37 MAJOR DEPRESSION | 1 0.01 63.38 MALAISE | 30 0.30 63.68 MALIGNANT MELANOMA | 3 0.03 63.71 MALIGNANT NEOPLASM PROGRESSION | 11 0.11 63.82 MALLORY-WEISS SYNDROME | 3 0.03 63.85 MALNUTRITION | 4 0.04 63.89 MANTLE CELL LYMPHOMA | 1 0.01 63.90 MASS | 2 0.02 63.92 MASTECTOMY | 1 0.01 63.93 MATERNAL CONDITION AFFECTING FOETUS | 1 0.01 63.94 MEDIASTINAL HAEMORRHAGE | 1 0.01 63.95 MEDICATION ERROR | 48 0.48 64.43 MEDICATION RESIDUE | 2 0.02 64.45 MEGAKARYOCYTES ABNORMAL | 1 0.01 64.46 MELAENA | 3 0.03 64.49 MELANOCYTIC NAEVUS | 3 0.03 64.52 MELANOSIS COLI | 1 0.01 64.53 MEMORY IMPAIRMENT | 16 0.16 64.69 MENIERE'S DISEASE | 1 0.01 64.70 MENINGIOMA | 3 0.03 64.73 MENINGITIS CRYPTOCOCCAL | 1 0.01 64.74 MENISCUS LESION | 3 0.03 64.77 MENTAL DISORDER | 6 0.06 64.83 MENTAL IMPAIRMENT | 1 0.01 64.84 MENTAL STATUS CHANGES | 16 0.16 65.00 METABOLIC ACIDOSIS | 10 0.10 65.10 METAPLASIA | 1 0.01 65.11 METASTASES TO CENTRAL NERVOUS SYSTEM | 2 0.02 65.13 METASTASES TO LIVER | 4 0.04 65.17 METASTASES TO LYMPH NODES | 1 0.01 65.18 METASTASES TO PERITONEUM | 1 0.01 65.19 METRORRHAGIA | 2 0.02 65.21 MICROANGIOPATHY | 1 0.01 65.22 MICROCEPHALY | 1 0.01 65.23 MICROCYTIC ANAEMIA | 3 0.03 65.26 MICTURITION DISORDER | 2 0.02 65.28 MICTURITION URGENCY | 2 0.02 65.30 MIDDLE INSOMNIA | 2 0.02 65.32 MIGRAINE | 10 0.10 65.42 MIGRAINE WITH AURA | 2 0.02 65.44 MIOSIS | 2 0.02 65.46 MITOCHONDRIAL TOXICITY | 1 0.01 65.47 MITRAL VALVE CALCIFICATION | 2 0.02 65.49 MITRAL VALVE INCOMPETENCE | 11 0.11 65.60 MITRAL VALVE PROLAPSE | 2 0.02 65.62 MOBILITY DECREASED | 6 0.06 65.68 MONARTHRITIS | 3 0.03 65.71 MOOD ALTERED | 4 0.04 65.75 MOOD SWINGS | 5 0.05 65.80 MORBID THOUGHTS | 1 0.01 65.81 MOTOR DYSFUNCTION | 2 0.02 65.83 MOUTH ULCERATION | 3 0.03 65.86 MOVEMENT DISORDER | 2 0.02 65.88 MUCOSAL DRYNESS | 1 0.01 65.89 MUCOSAL EROSION | 1 0.01 65.90 MUCOSAL INFLAMMATION | 5 0.05 65.95 MUCOUS STOOLS | 2 0.02 65.97 MULTI-ORGAN DISORDER | 12 0.12 66.09 MULTI-ORGAN FAILURE | 12 0.12 66.21 MULTIPLE ALLERGIES | 1 0.01 66.22 MULTIPLE DRUG OVERDOSE | 6 0.06 66.28 MULTIPLE DRUG OVERDOSE ACCIDENTAL | 1 0.01 66.29 MULTIPLE DRUG OVERDOSE INTENTIONAL | 2 0.02 66.31 MULTIPLE MYELOMA | 1 0.01 66.32 MULTIPLE SCLEROSIS | 6 0.06 66.38 MULTIPLE SCLEROSIS RELAPSE | 6 0.06 66.44 MUSCLE ABSCESS | 1 0.01 66.45 MUSCLE ATROPHY | 2 0.02 66.47 MUSCLE CONTRACTIONS INVOLUNTARY | 2 0.02 66.49 MUSCLE FATIGUE | 1 0.01 66.50 MUSCLE HAEMORRHAGE | 1 0.01 66.51 MUSCLE RIGIDITY | 5 0.05 66.56 MUSCLE SPASMS | 19 0.19 66.75 MUSCLE SPASTICITY | 1 0.01 66.76 MUSCLE STRAIN | 2 0.02 66.78 MUSCLE TIGHTNESS | 2 0.02 66.80 MUSCLE TWITCHING | 3 0.03 66.83 MUSCULAR DYSTROPHY | 1 0.01 66.84 MUSCULAR WEAKNESS | 5 0.05 66.89 MUSCULOSKELETAL CHEST PAIN | 4 0.04 66.93 MUSCULOSKELETAL DISCOMFORT | 2 0.02 66.95 MUSCULOSKELETAL DISORDER | 1 0.01 66.96 MUSCULOSKELETAL PAIN | 2 0.02 66.98 MUSCULOSKELETAL STIFFNESS | 10 0.10 67.08 MYALGIA | 27 0.27 67.35 MYASTHENIC SYNDROME | 1 0.01 67.36 MYCOBACTERIUM KANSASII INFECTION | 1 0.01 67.37 MYDRIASIS | 4 0.04 67.41 MYELITIS | 3 0.03 67.44 MYELODYSPLASTIC SYNDROME | 3 0.03 67.47 MYELOFIBROSIS | 1 0.01 67.48 MYELOPROLIFERATIVE DISORDER | 1 0.01 67.49 MYOCARDIAL INFARCTION | 195 1.95 69.44 MYOCARDIAL ISCHAEMIA | 16 0.16 69.60 MYOCARDITIS | 3 0.03 69.63 MYOCLONUS | 2 0.02 69.65 MYOGLOBIN BLOOD INCREASED | 1 0.01 69.66 MYOKYMIA | 1 0.01 69.67 MYOSITIS | 3 0.03 69.70 NAIL BED INFLAMMATION | 1 0.01 69.71 NAIL DISORDER | 2 0.02 69.73 NAIL INFECTION | 2 0.02 69.75 NASAL CONGESTION | 4 0.04 69.79 NASAL SEPTUM DEVIATION | 2 0.02 69.81 NASAL SEPTUM PERFORATION | 2 0.02 69.83 NASOPHARYNGITIS | 6 0.06 69.89 NAUSEA | 67 0.67 70.56 NECK INJURY | 3 0.03 70.59 NECK MASS | 1 0.01 70.60 NECK PAIN | 13 0.13 70.73 NECROSIS | 1 0.01 70.74 NECROTISING COLITIS | 1 0.01 70.75 NECROTISING ULCERATIVE GINGIVOSTOMATI.. | 1 0.01 70.76 NEONATAL ASPIRATION | 2 0.02 70.78 NEONATAL DISORDER | 3 0.03 70.81 NEONATAL RESPIRATORY ARREST | 1 0.01 70.82 NEONATAL RESPIRATORY DISTRESS SYNDROME | 2 0.02 70.84 NEOPLASM MALIGNANT | 4 0.04 70.88 NEOPLASM PROGRESSION | 1 0.01 70.89 NEOPLASM RECURRENCE | 1 0.01 70.90 NEPHRITIS INTERSTITIAL | 1 0.01 70.91 NEPHROGENIC ANAEMIA | 1 0.01 70.92 NEPHROLITHIASIS | 12 0.12 71.04 NEPHROPATHY TOXIC | 2 0.02 71.06 NEPHROTIC SYNDROME | 2 0.02 71.08 NERVE BLOCK | 2 0.02 71.10 NERVE COMPRESSION | 1 0.01 71.11 NERVE INJURY | 1 0.01 71.12 NERVE ROOT LESION | 1 0.01 71.13 NERVOUS SYSTEM DISORDER | 7 0.07 71.20 NERVOUSNESS | 10 0.10 71.30 NEURALGIA | 2 0.02 71.32 NEURODERMATITIS | 1 0.01 71.33 NEUROLEPTIC MALIGNANT SYNDROME | 6 0.06 71.39 NEUROLOGIC NEGLECT SYNDROME | 1 0.01 71.40 NEUROLOGICAL SYMPTOM | 4 0.04 71.44 NEUROMUSCULAR BLOCKADE | 1 0.01 71.45 NEUROPATHY | 7 0.07 71.52 NEUROPATHY PERIPHERAL | 6 0.06 71.58 NEUROTOXICITY | 1 0.01 71.59 NEUTROPENIA | 22 0.22 71.81 NEUTROPHIL COUNT ABNORMAL | 2 0.02 71.83 NEUTROPHIL COUNT DECREASED | 2 0.02 71.85 NEUTROPHIL COUNT INCREASED | 3 0.03 71.88 NEUTROPHIL PERCENTAGE DECREASED | 1 0.01 71.89 NEUTROPHIL PERCENTAGE INCREASED | 1 0.01 71.90 NIGHT BLINDNESS | 2 0.02 71.92 NIGHT SWEATS | 3 0.03 71.95 NIGHTMARE | 7 0.07 72.02 NO ADVERSE DRUG EFFECT | 2 0.02 72.04 NO ADVERSE EFFECT | 4 0.04 72.08 NO REACTION ON PREVIOUS EXPOSURE TO D.. | 1 0.01 72.09 NO THERAPEUTIC RESPONSE | 1 0.01 72.10 NOCARDIOSIS | 1 0.01 72.11 NOCTURIA | 3 0.03 72.14 NODAL RHYTHM | 1 0.01 72.15 NODULE | 1 0.01 72.16 NON-CARDIAC CHEST PAIN | 6 0.06 72.22 NON-HODGKIN'S LYMPHOMA | 1 0.01 72.23 NON-SMALL CELL LUNG CANCER | 1 0.01 72.24 NOREPINEPHRINE INCREASED | 2 0.02 72.26 NORMAL NEWBORN | 1 0.01 72.27 NORMOCHROMIC NORMOCYTIC ANAEMIA | 1 0.01 72.28 NOSE DEFORMITY | 1 0.01 72.29 NUCHAL RIGIDITY | 1 0.01 72.30 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 1 0.01 72.31 NYSTAGMUS | 1 0.01 72.32 OBESITY | 9 0.09 72.41 OBSESSIVE-COMPULSIVE DISORDER | 2 0.02 72.43 OBSTRUCTION | 2 0.02 72.45 OBSTRUCTION GASTRIC | 1 0.01 72.46 OBSTRUCTIVE AIRWAYS DISORDER | 2 0.02 72.48 OBSTRUCTIVE UROPATHY | 1 0.01 72.49 OCCULT BLOOD POSITIVE | 3 0.03 72.52 OCULAR HYPERAEMIA | 2 0.02 72.54 OCULAR ICTERUS | 3 0.03 72.57 OCULAR VASCULAR DISORDER | 2 0.02 72.59 OCULOGYRATION | 1 0.01 72.60 ODYNOPHAGIA | 1 0.01 72.61 OEDEMA | 12 0.12 72.73 OEDEMA PERIPHERAL | 42 0.42 73.15 OESOPHAGEAL ACHALASIA | 1 0.01 73.16 OESOPHAGEAL CANDIDIASIS | 1 0.01 73.17 OESOPHAGEAL CARCINOMA | 1 0.01 73.18 OESOPHAGEAL DISORDER | 4 0.04 73.22 OESOPHAGEAL OBSTRUCTION | 2 0.02 73.24 OESOPHAGEAL PAIN | 1 0.01 73.25 OESOPHAGEAL SPASM | 1 0.01 73.26 OESOPHAGEAL STENOSIS | 4 0.04 73.30 OESOPHAGEAL ULCER | 1 0.01 73.31 OESOPHAGEAL ULCER HAEMORRHAGE | 1 0.01 73.32 OESOPHAGEAL VARICES HAEMORRHAGE | 1 0.01 73.33 OESOPHAGITIS | 7 0.07 73.40 OESTROGEN RECEPTOR ASSAY POSITIVE | 6 0.06 73.46 OFF LABEL USE | 3 0.03 73.49 OLIGURIA | 1 0.01 73.50 ONYCHOMYCOSIS | 1 0.01 73.51 OPEN WOUND | 1 0.01 73.52 OPTIC NERVE DISORDER | 2 0.02 73.54 OPTIC NEURITIS | 1 0.01 73.55 OPTIC NEURITIS RETROBULBAR | 1 0.01 73.56 ORAL DISCOMFORT | 1 0.01 73.57 ORAL INTAKE REDUCED | 4 0.04 73.61 ORAL MUCOSA EROSION | 1 0.01 73.62 ORAL MUCOSAL BLISTERING | 2 0.02 73.64 ORAL MUCOSAL DISORDER | 1 0.01 73.65 ORAL PAIN | 1 0.01 73.66 ORCHITIS NONINFECTIVE | 1 0.01 73.67 ORGAN FAILURE | 3 0.03 73.70 OROPHARYNGEAL SPASM | 1 0.01 73.71 ORTHOPNOEA | 2 0.02 73.73 ORTHOSTATIC HYPOTENSION | 9 0.09 73.82 OSCILLOPSIA | 1 0.01 73.83 OSTEITIS DEFORMANS | 1 0.01 73.84 OSTEOARTHRITIS | 14 0.14 73.98 OSTEOLYSIS | 2 0.02 74.00 OSTEOMA | 1 0.01 74.01 OSTEOMALACIA | 1 0.01 74.02 OSTEOMYELITIS | 4 0.04 74.06 OSTEOMYELITIS CHRONIC | 2 0.02 74.08 OSTEONECROSIS | 11 0.11 74.19 OSTEOPENIA | 3 0.03 74.22 OSTEOPOROSIS | 4 0.04 74.26 OSTEOPOROTIC FRACTURE | 1 0.01 74.27 OTITIS MEDIA | 1 0.01 74.28 OVARIAN CANCER | 1 0.01 74.29 OVARIAN DISORDER | 2 0.02 74.31 OVARIAN MASS | 1 0.01 74.32 OVERDOSE | 46 0.46 74.78 OVERWEIGHT | 1 0.01 74.79 OXYGEN SATURATION DECREASED | 9 0.09 74.88 PACEMAKER COMPLICATION | 1 0.01 74.89 PAIN | 48 0.48 75.37 PAIN IN EXTREMITY | 30 0.30 75.67 PAIN IN JAW | 3 0.03 75.70 PAINFUL DEFAECATION | 1 0.01 75.71 PAINFUL ERECTION | 1 0.01 75.72 PAINFUL RESPIRATION | 2 0.02 75.74 PALLOR | 3 0.03 75.77 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 1 0.01 75.78 PALPITATIONS | 21 0.21 75.99 PANCREATIC CARCINOMA | 3 0.03 76.02 PANCREATIC CYST | 1 0.01 76.03 PANCREATIC DISORDER | 2 0.02 76.05 PANCREATIC OPERATION | 1 0.01 76.06 PANCREATITIS | 10 0.10 76.16 PANCREATITIS ACUTE | 2 0.02 76.18 PANCYTOPENIA | 10 0.10 76.28 PANIC ATTACK | 12 0.12 76.40 PANIC REACTION | 1 0.01 76.41 PAPILLOEDEMA | 1 0.01 76.42 PAPILLOMA VIRAL INFECTION | 1 0.01 76.43 PARAESTHESIA | 15 0.15 76.58 PARAESTHESIA ORAL | 2 0.02 76.60 PARANOIA | 4 0.04 76.64 PARAPLEGIA | 1 0.01 76.65 PARATHYROID DISORDER | 2 0.02 76.67 PARESIS | 2 0.02 76.69 PARKINSON'S DISEASE | 2 0.02 76.71 PARKINSONISM | 1 0.01 76.72 PAROTITIS | 1 0.01 76.73 PATHOGEN RESISTANCE | 2 0.02 76.75 PATHOLOGICAL FRACTURE | 1 0.01 76.76 PELVIC FRACTURE | 2 0.02 76.78 PELVIC PAIN | 1 0.01 76.79 PEMPHIGUS | 1 0.01 76.80 PENILE DISCHARGE | 1 0.01 76.81 PENILE SIZE REDUCED | 1 0.01 76.82 PENILE ULCERATION | 1 0.01 76.83 PENIS DISORDER | 1 0.01 76.84 PEPTIC ULCER | 2 0.02 76.86 PERICARDIAL EFFUSION | 5 0.05 76.91 PERICARDIAL HAEMORRHAGE | 1 0.01 76.92 PERICARDITIS | 5 0.05 76.97 PERINEAL PAIN | 1 0.01 76.98 PERIODONTAL DISEASE | 1 0.01 76.99 PERIORBITAL OEDEMA | 2 0.02 77.01 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 2 0.02 77.03 PERIPHERAL COLDNESS | 5 0.05 77.08 PERIPHERAL ISCHAEMIA | 1 0.01 77.09 PERIPHERAL SENSORY NEUROPATHY | 1 0.01 77.10 PERIRECTAL ABSCESS | 1 0.01 77.11 PERITONITIS | 4 0.04 77.15 PERONEAL NERVE PALSY | 3 0.03 77.18 PERSONALITY CHANGE | 2 0.02 77.20 PETECHIAE | 1 0.01 77.21 PHARMACEUTICAL PRODUCT COMPLAINT | 37 0.37 77.58 PHARYNGEAL HAEMORRHAGE | 1 0.01 77.59 PHARYNGEAL OEDEMA | 2 0.02 77.61 PHARYNGEAL ULCERATION | 1 0.01 77.62 PHARYNGITIS | 4 0.04 77.66 PHARYNGOLARYNGEAL PAIN | 3 0.03 77.69 PHLEBITIS | 2 0.02 77.71 PHOTOPHOBIA | 4 0.04 77.75 PHOTOPSIA | 1 0.01 77.76 PHOTOSENSITIVITY REACTION | 2 0.02 77.78 PITTING OEDEMA | 2 0.02 77.80 PITUITARY TUMOUR BENIGN | 2 0.02 77.82 PITYRIASIS | 1 0.01 77.83 PLANTAR FASCIITIS | 4 0.04 77.87 PLATELET COUNT DECREASED | 13 0.13 78.00 PLATELET COUNT INCREASED | 4 0.04 78.04 PLEURAL EFFUSION | 22 0.22 78.26 PLEURAL MESOTHELIOMA | 1 0.01 78.27 PLEURISY | 3 0.03 78.30 PLEUROTHOTONUS | 3 0.03 78.33 PNEUMOCYSTIS JIROVECI INFECTION | 1 0.01 78.34 PNEUMOCYSTIS JIROVECI PNEUMONIA | 4 0.04 78.38 PNEUMONIA | 54 0.54 78.92 PNEUMONIA ASPIRATION | 4 0.04 78.96 PNEUMONIA BACTERIAL | 3 0.03 78.99 PNEUMONIA CHLAMYDIAL | 1 0.01 79.00 PNEUMONIA CYTOMEGALOVIRAL | 1 0.01 79.01 PNEUMONIA FUNGAL | 1 0.01 79.02 PNEUMONIA PNEUMOCOCCAL | 2 0.02 79.04 PNEUMONIA STREPTOCOCCAL | 2 0.02 79.06 PNEUMONITIS | 2 0.02 79.08 PNEUMOPERICARDIUM | 2 0.02 79.10 PNEUMOTHORAX | 6 0.06 79.16 PO2 INCREASED | 1 0.01 79.17 POLLAKIURIA | 5 0.05 79.22 POLYARTHRITIS | 2 0.02 79.24 POLYCYSTIC LIVER DISEASE | 1 0.01 79.25 POLYCYTHAEMIA | 1 0.01 79.26 POLYDIPSIA | 3 0.03 79.29 POLYMYALGIA RHEUMATICA | 2 0.02 79.31 POLYMYOSITIS | 2 0.02 79.33 POLYNEUROPATHY | 3 0.03 79.36 POLYP | 5 0.05 79.41 POLYPECTOMY | 1 0.01 79.42 POLYSUBSTANCE ABUSE | 4 0.04 79.46 POLYSUBSTANCE DEPENDENCE | 1 0.01 79.47 POLYTRAUMATISM | 1 0.01 79.48 POLYURIA | 5 0.05 79.53 POOR SUCKING REFLEX | 1 0.01 79.54 PORTAL HYPERTENSION | 1 0.01 79.55 PORTAL VEIN PRESSURE INCREASED | 1 0.01 79.56 PORTAL VEIN STENOSIS | 1 0.01 79.57 PORTAL VEIN THROMBOSIS | 2 0.02 79.59 POST PROCEDURAL COMPLICATION | 13 0.13 79.72 POST PROCEDURAL HAEMATOMA | 1 0.01 79.73 POST PROCEDURAL HAEMORRHAGE | 2 0.02 79.75 POST PROCEDURAL NAUSEA | 1 0.01 79.76 POST-TRAUMATIC STRESS DISORDER | 1 0.01 79.77 POSTINFARCTION ANGINA | 1 0.01 79.78 POSTOPERATIVE FEVER | 1 0.01 79.79 POSTOPERATIVE ILEUS | 1 0.01 79.80 POSTOPERATIVE INFECTION | 2 0.02 79.82 POSTOPERATIVE WOUND INFECTION | 1 0.01 79.83 POSTPARTUM HYPOPITUITARISM | 1 0.01 79.84 POSTURE ABNORMAL | 1 0.01 79.85 POUCHITIS | 1 0.01 79.86 PRECOCIOUS PUBERTY | 1 0.01 79.87 PREGNANCY | 9 0.09 79.96 PREGNANCY INDUCED HYPERTENSION | 1 0.01 79.97 PREGNANCY WITH INJECTABLE CONTRACEPTIVE | 1 0.01 79.98 PREMATURE BABY | 3 0.03 80.01 PREMATURE LABOUR | 5 0.05 80.06 PRESCRIBED OVERDOSE | 3 0.03 80.09 PRIAPISM | 8 0.08 80.17 PROCEDURAL COMPLICATION | 4 0.04 80.21 PROCEDURAL PAIN | 2 0.02 80.23 PROCTALGIA | 1 0.01 80.24 PROCTITIS | 2 0.02 80.26 PROCTITIS ULCERATIVE | 1 0.01 80.27 PROGESTERONE RECEPTOR ASSAY POSITIVE | 5 0.05 80.32 PROLONGED LABOUR | 1 0.01 80.33 PROPOFOL INFUSION SYNDROME | 1 0.01 80.34 PROSTATE CANCER | 8 0.08 80.42 PROSTATE CANCER STAGE II | 1 0.01 80.43 PROSTATE EXAMINATION ABNORMAL | 1 0.01 80.44 PROSTATIC PAIN | 1 0.01 80.45 PROSTATISM | 1 0.01 80.46 PROSTATITIS | 2 0.02 80.48 PROTEIN URINE | 1 0.01 80.49 PROTEIN URINE PRESENT | 2 0.02 80.51 PROTEINURIA | 2 0.02 80.53 PROTHROMBIN LEVEL DECREASED | 5 0.05 80.58 PROTHROMBIN TIME | 1 0.01 80.59 PROTHROMBIN TIME PROLONGED | 4 0.04 80.63 PRURIGO | 1 0.01 80.64 PRURITUS | 25 0.25 80.89 PRURITUS ANI | 1 0.01 80.90 PRURITUS GENERALISED | 5 0.05 80.95 PSEUDOFOLLICULITIS BARBAE | 1 0.01 80.96 PSEUDOMONAS INFECTION | 5 0.05 81.01 PSEUDOPHAKIA | 1 0.01 81.02 PSEUDOPOLYP | 2 0.02 81.04 PSEUDOPOLYPOSIS | 1 0.01 81.05 PSORIASIS | 8 0.08 81.13 PSYCHIATRIC SYMPTOM | 2 0.02 81.15 PSYCHOMOTOR HYPERACTIVITY | 2 0.02 81.17 PSYCHOTIC DISORDER | 6 0.06 81.23 PULMONARY CALCIFICATION | 1 0.01 81.24 PULMONARY EMBOLISM | 46 0.46 81.70 PULMONARY FIBROSIS | 9 0.09 81.79 PULMONARY GRANULOMA | 1 0.01 81.80 PULMONARY HYPERTENSION | 6 0.06 81.86 PULMONARY MASS | 1 0.01 81.87 PULMONARY MYCOSIS | 1 0.01 81.88 PULMONARY OEDEMA | 10 0.10 81.98 PULMONARY THROMBOSIS | 2 0.02 82.00 PULMONARY TUBERCULOSIS | 1 0.01 82.01 PULSE ABSENT | 3 0.03 82.04 PUPILLARY REFLEX IMPAIRED | 1 0.01 82.05 PURPURA | 10 0.10 82.15 PURULENT DISCHARGE | 2 0.02 82.17 PUSTULAR PSORIASIS | 2 0.02 82.19 PYELECTASIA | 1 0.01 82.20 PYELONEPHRITIS | 1 0.01 82.21 PYOTHORAX | 1 0.01 82.22 PYREXIA | 70 0.70 82.92 PYURIA | 2 0.02 82.94 RADIAL NERVE PALSY | 1 0.01 82.95 RADIATION SKIN INJURY | 1 0.01 82.96 RADICULOPATHY | 1 0.01 82.97 RALES | 1 0.01 82.98 RASH | 37 0.37 83.35 RASH ERYTHEMATOUS | 10 0.10 83.45 RASH GENERALISED | 5 0.05 83.50 RASH MACULAR | 4 0.04 83.54 RASH MACULO-PAPULAR | 7 0.07 83.61 RASH PAPULAR | 3 0.03 83.64 RASH PAPULOSQUAMOUS | 1 0.01 83.65 RASH PRURITIC | 5 0.05 83.70 RASH PUSTULAR | 4 0.04 83.74 RASH VESICULAR | 2 0.02 83.76 RAYNAUD'S PHENOMENON | 2 0.02 83.78 REACTION TO DRUG EXCIPIENTS | 2 0.02 83.80 RECTAL HAEMORRHAGE | 11 0.11 83.91 RECTAL POLYP | 2 0.02 83.93 RECTAL SPASM | 1 0.01 83.94 RECURRENT CANCER | 1 0.01 83.95 RED BLOOD CELL COUNT DECREASED | 5 0.05 84.00 RED BLOOD CELL SCHISTOCYTES PRESENT | 1 0.01 84.01 RED BLOOD CELL SEDIMENTATION RATE INC.. | 2 0.02 84.03 REFRACTORY ANAEMIA | 2 0.02 84.05 REFRACTORY ANAEMIA WITH EXCESS BLASTS.. | 1 0.01 84.06 REFUSAL OF TREATMENT BY PATIENT | 4 0.04 84.10 REITER'S SYNDROME | 1 0.01 84.11 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 1 0.01 84.12 RENAL ARTERY OCCLUSION | 1 0.01 84.13 RENAL ARTERY STENT PLACEMENT | 1 0.01 84.14 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 1 0.01 84.15 RENAL COLIC | 2 0.02 84.17 RENAL CYST | 7 0.07 84.24 RENAL DISORDER | 8 0.08 84.32 RENAL FAILURE | 37 0.37 84.69 RENAL FAILURE ACUTE | 31 0.31 85.00 RENAL FAILURE CHRONIC | 9 0.09 85.09 RENAL HAEMATOMA | 1 0.01 85.10 RENAL IMPAIRMENT | 12 0.12 85.22 RENAL INFARCT | 1 0.01 85.23 RENAL PAIN | 2 0.02 85.25 RENAL PAPILLARY NECROSIS | 1 0.01 85.26 RENAL TRANSPLANT | 1 0.01 85.27 RENAL TUBULAR NECROSIS | 3 0.03 85.30 RESPIRATORY ACIDOSIS | 3 0.03 85.33 RESPIRATORY ALKALOSIS | 1 0.01 85.34 RESPIRATORY ARREST | 7 0.07 85.41 RESPIRATORY DEPRESSION | 5 0.05 85.46 RESPIRATORY DISORDER | 5 0.05 85.51 RESPIRATORY DISTRESS | 5 0.05 85.56 RESPIRATORY FAILURE | 31 0.31 85.87 RESPIRATORY RATE DECREASED | 4 0.04 85.91 RESPIRATORY RATE INCREASED | 2 0.02 85.93 RESPIRATORY TRACT INFECTION | 6 0.06 85.99 RESTLESS LEGS SYNDROME | 1 0.01 86.00 RESTLESSNESS | 5 0.05 86.05 RESUSCITATION | 1 0.01 86.06 RETCHING | 3 0.03 86.09 RETINAL ARTERY EMBOLISM | 1 0.01 86.10 RETINAL ARTERY OCCLUSION | 1 0.01 86.11 RETINAL ARTERY THROMBOSIS | 1 0.01 86.12 RETINAL DEGENERATION | 1 0.01 86.13 RETINAL DETACHMENT | 3 0.03 86.16 RETINAL DISORDER | 1 0.01 86.17 RETINAL HAEMORRHAGE | 2 0.02 86.19 RETINAL PIGMENT EPITHELIOPATHY | 2 0.02 86.21 RETINAL VEIN THROMBOSIS | 1 0.01 86.22 RETROGNATHIA | 1 0.01 86.23 RETROPERITONEAL HAEMATOMA | 1 0.01 86.24 RETROPERITONEAL HAEMORRHAGE | 2 0.02 86.26 REVERSIBLE POSTERIOR LEUKOENCEPHALOPA.. | 1 0.01 86.27 RHABDOMYOLYSIS | 19 0.19 86.46 RHEUMATOID ARTHRITIS | 10 0.10 86.56 RHEUMATOID FACTOR POSITIVE | 1 0.01 86.57 RHINITIS | 1 0.01 86.58 RHINITIS ALLERGIC | 4 0.04 86.62 RHINORRHOEA | 4 0.04 86.66 RIB FRACTURE | 3 0.03 86.69 RICKETS | 1 0.01 86.70 RIGHT VENTRICULAR FAILURE | 4 0.04 86.74 ROAD TRAFFIC ACCIDENT | 11 0.11 86.85 ROSEOLA | 1 0.01 86.86 ROTATOR CUFF SYNDROME | 4 0.04 86.90 SALIVARY HYPERSECRETION | 4 0.04 86.94 SALPINGITIS | 1 0.01 86.95 SARCOIDOSIS | 3 0.03 86.98 SCAR | 4 0.04 87.02 SCHIZOAFFECTIVE DISORDER | 1 0.01 87.03 SCHIZOPHRENIA | 1 0.01 87.04 SCHOOL REFUSAL | 1 0.01 87.05 SCIATICA | 2 0.02 87.07 SCOLIOSIS | 1 0.01 87.08 SCOTOMA | 2 0.02 87.10 SCRATCH | 1 0.01 87.11 SCREAMING | 2 0.02 87.13 SCROTAL HAEMATOCOELE | 1 0.01 87.14 SEASONAL ALLERGY | 1 0.01 87.15 SEBORRHOEIC KERATOSIS | 3 0.03 87.18 SEDATION | 5 0.05 87.23 SELF ESTEEM DECREASED | 2 0.02 87.25 SELF MUTILATION | 1 0.01 87.26 SELF-MEDICATION | 2 0.02 87.28 SENSATION OF HEAVINESS | 2 0.02 87.30 SENSE OF OPPRESSION | 1 0.01 87.31 SENSORY DISTURBANCE | 4 0.04 87.35 SENSORY LOSS | 1 0.01 87.36 SEPSIS | 30 0.30 87.66 SEPTIC SHOCK | 10 0.10 87.76 SEROMA | 1 0.01 87.77 SEROTONIN SYNDROME | 3 0.03 87.80 SERUM SICKNESS | 3 0.03 87.83 SEXUAL DYSFUNCTION | 1 0.01 87.84 SHOCK | 12 0.12 87.96 SHOCK HAEMORRHAGIC | 1 0.01 87.97 SHOULDER ARTHROPLASTY | 1 0.01 87.98 SHOULDER OPERATION | 2 0.02 88.00 SHOULDER PAIN | 9 0.09 88.09 SHUNT INFECTION | 1 0.01 88.10 SICK SINUS SYNDROME | 5 0.05 88.15 SIGMOIDITIS | 1 0.01 88.16 SIMILAR REACTION ON PREVIOUS EXPOSURE.. | 1 0.01 88.17 SINGLE FUNCTIONAL KIDNEY | 1 0.01 88.18 SINGLE UMBILICAL ARTERY | 1 0.01 88.19 SINUS ARRHYTHMIA | 1 0.01 88.20 SINUS BRADYCARDIA | 7 0.07 88.27 SINUS CONGESTION | 2 0.02 88.29 SINUS DISORDER | 3 0.03 88.32 SINUS HEADACHE | 1 0.01 88.33 SINUS OPERATION | 2 0.02 88.35 SINUS TACHYCARDIA | 7 0.07 88.42 SINUSITIS | 15 0.15 88.57 SJOGREN'S SYNDROME | 2 0.02 88.59 SKIN ATROPHY | 2 0.02 88.61 SKIN BURNING SENSATION | 2 0.02 88.63 SKIN CANCER | 2 0.02 88.65 SKIN DISCOLOURATION | 2 0.02 88.67 SKIN DISORDER | 7 0.07 88.74 SKIN EXFOLIATION | 5 0.05 88.79 SKIN GRAFT | 1 0.01 88.80 SKIN INFECTION | 1 0.01 88.81 SKIN IRRITATION | 2 0.02 88.83 SKIN LACERATION | 5 0.05 88.88 SKIN LESION | 9 0.09 88.97 SKIN NECROSIS | 1 0.01 88.98 SKIN NEOPLASM EXCISION | 1 0.01 88.99 SKIN PAPILLOMA | 3 0.03 89.02 SKIN TEST POSITIVE | 1 0.01 89.03 SKIN ULCER | 9 0.09 89.12 SKIN WARM | 1 0.01 89.13 SLEEP APNOEA SYNDROME | 9 0.09 89.22 SLEEP DISORDER | 16 0.16 89.38 SMALL FOR DATES BABY | 1 0.01 89.39 SMALL INTESTINAL OBSTRUCTION | 4 0.04 89.43 SMALL INTESTINAL PERFORATION | 1 0.01 89.44 SMEAR CERVIX ABNORMAL | 1 0.01 89.45 SNEEZING | 2 0.02 89.47 SNORING | 1 0.01 89.48 SOCIAL AVOIDANT BEHAVIOUR | 2 0.02 89.50 SOCIAL PROBLEM | 1 0.01 89.51 SOMNOLENCE | 37 0.37 89.88 SPEECH DISORDER | 9 0.09 89.97 SPINA BIFIDA | 1 0.01 89.98 SPINAL COLUMN STENOSIS | 3 0.03 90.01 SPINAL CORD COMPRESSION | 2 0.02 90.03 SPINAL DISORDER | 1 0.01 90.04 SPINAL FRACTURE | 7 0.07 90.11 SPINAL LAMINECTOMY | 2 0.02 90.13 SPINAL OSTEOARTHRITIS | 4 0.04 90.17 SPINAL X-RAY ABNORMAL | 1 0.01 90.18 SPLENIC INFARCTION | 1 0.01 90.19 SPLENOMEGALY | 3 0.03 90.22 SPONDYLOARTHROPATHY | 1 0.01 90.23 SPUTUM DISCOLOURED | 2 0.02 90.25 STAPHYLOCOCCAL ABSCESS | 2 0.02 90.27 STAPHYLOCOCCAL BACTERAEMIA | 2 0.02 90.29 STAPHYLOCOCCAL INFECTION | 11 0.11 90.40 STAPHYLOCOCCAL SEPSIS | 3 0.03 90.43 STATUS ASTHMATICUS | 1 0.01 90.44 STATUS EPILEPTICUS | 1 0.01 90.45 STEM CELL TRANSPLANT | 2 0.02 90.47 STENT OCCLUSION | 4 0.04 90.51 STEVENS-JOHNSON SYNDROME | 11 0.11 90.62 STILLBIRTH | 3 0.03 90.65 STOMACH DISCOMFORT | 6 0.06 90.71 STOMATITIS | 5 0.05 90.76 STRABISMUS | 1 0.01 90.77 STREPTOCOCCAL SEPSIS | 2 0.02 90.79 STRESS | 12 0.12 90.91 STRESS FRACTURE | 1 0.01 90.92 STRESS INCONTINENCE | 1 0.01 90.93 STRIDOR | 2 0.02 90.95 SUBARACHNOID HAEMORRHAGE | 3 0.03 90.98 SUBCUTANEOUS ABSCESS | 1 0.01 90.99 SUBCUTANEOUS HAEMATOMA | 1 0.01 91.00 SUBDURAL EMPYEMA | 1 0.01 91.01 SUBDURAL HAEMATOMA | 2 0.02 91.03 SUBDURAL HAEMORRHAGE | 1 0.01 91.04 SUDDEN CARDIAC DEATH | 6 0.06 91.10 SUDDEN DEATH | 11 0.11 91.21 SUDDEN HEARING LOSS | 1 0.01 91.22 SUDDEN INFANT DEATH SYNDROME | 1 0.01 91.23 SUDDEN ONSET OF SLEEP | 1 0.01 91.24 SUICIDAL IDEATION | 19 0.19 91.43 SUICIDE ATTEMPT | 12 0.12 91.55 SULPHAEMOGLOBINAEMIA | 1 0.01 91.56 SUPERINFECTION | 2 0.02 91.58 SUPRAVENTRICULAR EXTRASYSTOLES | 4 0.04 91.62 SUPRAVENTRICULAR TACHYCARDIA | 4 0.04 91.66 SURGERY | 7 0.07 91.73 SURGICAL PROCEDURE REPEATED | 1 0.01 91.74 SWELLING | 7 0.07 91.81 SWELLING FACE | 10 0.10 91.91 SWOLLEN TONGUE | 3 0.03 91.94 SYNCOPE | 26 0.26 92.20 SYNCOPE VASOVAGAL | 2 0.02 92.22 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME | 1 0.01 92.23 SYSTEMIC LUPUS ERYTHEMATOSUS | 8 0.08 92.31 TACHYARRHYTHMIA | 2 0.02 92.33 TACHYCARDIA | 27 0.27 92.60 TACHYPNOEA | 6 0.06 92.66 TARDIVE DYSKINESIA | 1 0.01 92.67 TEMPERATURE INTOLERANCE | 1 0.01 92.68 TEMPORAL LOBE EPILEPSY | 1 0.01 92.69 TENDERNESS | 1 0.01 92.70 TENDON DISORDER | 7 0.07 92.77 TENDON INJURY | 1 0.01 92.78 TENDON RUPTURE | 9 0.09 92.87 TENDONITIS | 6 0.06 92.93 TENSION HEADACHE | 2 0.02 92.95 TESTICULAR DISORDER | 2 0.02 92.97 TESTICULAR PAIN | 1 0.01 92.98 TESTICULAR SWELLING | 1 0.01 92.99 THALAMIC INFARCTION | 1 0.01 93.00 THEFT | 1 0.01 93.01 THERAPEUTIC AGENT TOXICITY | 1 0.01 93.02 THERAPEUTIC RESPONSE DECREASED | 9 0.09 93.11 THERAPEUTIC RESPONSE UNEXPECTED WITH .. | 1 0.01 93.12 THERAPY NON-RESPONDER | 5 0.05 93.17 THINKING ABNORMAL | 9 0.09 93.26 THIRST | 3 0.03 93.29 THORACIC VERTEBRAL FRACTURE | 1 0.01 93.30 THROAT IRRITATION | 1 0.01 93.31 THROAT TIGHTNESS | 2 0.02 93.33 THROMBOCYTHAEMIA | 2 0.02 93.35 THROMBOCYTOPENIA | 22 0.22 93.57 THROMBOCYTOPENIC PURPURA | 2 0.02 93.59 THROMBOPHLEBITIS | 2 0.02 93.61 THROMBOPHLEBITIS SUPERFICIAL | 4 0.04 93.65 THROMBOSIS | 31 0.31 93.96 THROMBOSIS IN DEVICE | 2 0.02 93.98 THROMBOTIC MICROANGIOPATHY | 2 0.02 94.00 THROMBOTIC THROMBOCYTOPENIC PURPURA | 3 0.03 94.03 THYROID GLAND CANCER | 3 0.03 94.06 THYROID NEOPLASM | 1 0.01 94.07 THYROIDITIS | 1 0.01 94.08 TIBIA FRACTURE | 2 0.02 94.10 TIC | 1 0.01 94.11 TINEA CAPITIS | 1 0.01 94.12 TINEA CRURIS | 1 0.01 94.13 TINEA PEDIS | 1 0.01 94.14 TINNITUS | 4 0.04 94.18 TOE AMPUTATION | 3 0.03 94.21 TOE DEFORMITY | 1 0.01 94.22 TOE OPERATION | 1 0.01 94.23 TONGUE BITING | 1 0.01 94.24 TONGUE DISORDER | 1 0.01 94.25 TONGUE OEDEMA | 1 0.01 94.26 TONGUE SPASM | 1 0.01 94.27 TONIC CONVULSION | 1 0.01 94.28 TOOTH DISORDER | 3 0.03 94.31 TOOTH EXTRACTION | 3 0.03 94.34 TOOTH FRACTURE | 1 0.01 94.35 TOOTH LOSS | 2 0.02 94.37 TOOTHACHE | 2 0.02 94.39 TOXIC EPIDERMAL NECROLYSIS | 2 0.02 94.41 TOXIC SKIN ERUPTION | 2 0.02 94.43 TOXICOLOGIC TEST ABNORMAL | 1 0.01 94.44 TRACHEAL DISORDER | 1 0.01 94.45 TRANSAMINASES INCREASED | 8 0.08 94.53 TRANSIENT ISCHAEMIC ATTACK | 30 0.30 94.83 TRAUMATIC HAEMATOMA | 1 0.01 94.84 TREATMENT NONCOMPLIANCE | 12 0.12 94.96 TREATMENT RELATED SECONDARY MALIGNANCY | 4 0.04 95.00 TREMOR | 22 0.22 95.22 TRICUSPID VALVE INCOMPETENCE | 8 0.08 95.30 TRIGEMINAL NEURALGIA | 1 0.01 95.31 TRIGGER FINGER | 1 0.01 95.32 TRIPLE VESSEL BYPASS GRAFT | 1 0.01 95.33 TRISMUS | 1 0.01 95.34 TRISOMY 21 | 1 0.01 95.35 TROPONIN INCREASED | 1 0.01 95.36 TUBERCULOSIS | 8 0.08 95.44 TUBERCULOSIS GASTROINTESTINAL | 1 0.01 95.45 TUBERCULOUS PLEURISY | 1 0.01 95.46 TUBULOINTERSTITIAL NEPHRITIS | 1 0.01 95.47 TUMOUR HAEMORRHAGE | 1 0.01 95.48 TUMOUR LYSIS SYNDROME | 2 0.02 95.50 TYMPANIC MEMBRANE ATROPHIC | 1 0.01 95.51 TYMPANIC MEMBRANE HYPERAEMIA | 1 0.01 95.52 TYMPANIC MEMBRANE PERFORATION | 1 0.01 95.53 ULCER | 7 0.07 95.60 ULCER HAEMORRHAGE | 3 0.03 95.63 ULTRASOUND SCAN ABNORMAL | 1 0.01 95.64 UMBILICAL CORD ABNORMALITY | 2 0.02 95.66 UMBILICAL CORD AROUND NECK | 4 0.04 95.70 UNEVALUABLE EVENT | 1 0.01 95.71 UNRESPONSIVE TO PAIN STIMULI | 1 0.01 95.72 UNWANTED AWARENESS DURING ANAESTHESIA | 1 0.01 95.73 UPPER GASTROINTESTINAL HAEMORRHAGE | 2 0.02 95.75 UPPER LIMB FRACTURE | 4 0.04 95.79 UPPER RESPIRATORY TRACT INFECTION | 7 0.07 95.86 URETERIC OBSTRUCTION | 1 0.01 95.87 URETERIC STENOSIS | 1 0.01 95.88 URETHRAL CARUNCLE | 1 0.01 95.89 URETHRITIS | 1 0.01 95.90 URGE INCONTINENCE | 1 0.01 95.91 URINARY INCONTINENCE | 3 0.03 95.94 URINARY RETENTION | 5 0.05 95.99 URINARY TRACT INFECTION | 24 0.24 96.23 URINARY TRACT INFECTION BACTERIAL | 2 0.02 96.25 URINE ABNORMALITY | 1 0.01 96.26 URINE ANALYSIS ABNORMAL | 1 0.01 96.27 URINE OUTPUT DECREASED | 5 0.05 96.32 URINE URIC ACID INCREASED | 1 0.01 96.33 UROSEPSIS | 1 0.01 96.34 URTICARIA | 9 0.09 96.43 UTERINE CANCER | 3 0.03 96.46 UTERINE DISORDER | 1 0.01 96.47 UTERINE HAEMORRHAGE | 1 0.01 96.48 UTERINE LEIOMYOMA | 1 0.01 96.49 UTERINE MASS | 1 0.01 96.50 UVEITIS | 1 0.01 96.51 VAGINAL HAEMORRHAGE | 3 0.03 96.54 VAGINAL INFECTION | 1 0.01 96.55 VAGINAL PAIN | 2 0.02 96.57 VAGINAL PROLAPSE | 1 0.01 96.58 VARICES OESOPHAGEAL | 2 0.02 96.60 VARICOCELE | 1 0.01 96.61 VASCULAR BYPASS GRAFT | 1 0.01 96.62 VASCULAR DEMENTIA | 1 0.01 96.63 VASCULAR OPERATION | 1 0.01 96.64 VASCULAR RUPTURE | 2 0.02 96.66 VASCULITIS | 3 0.03 96.69 VASCULITIS NECROTISING | 1 0.01 96.70 VASOCONSTRICTION | 1 0.01 96.71 VENOOCCLUSIVE DISEASE | 1 0.01 96.72 VENOOCCLUSIVE LIVER DISEASE | 1 0.01 96.73 VENOUS INSUFFICIENCY | 1 0.01 96.74 VENOUS THROMBOSIS | 1 0.01 96.75 VENOUS THROMBOSIS LIMB | 1 0.01 96.76 VENTRICULAR ARRHYTHMIA | 1 0.01 96.77 VENTRICULAR DYSFUNCTION | 4 0.04 96.81 VENTRICULAR EXTRASYSTOLES | 6 0.06 96.87 VENTRICULAR FIBRILLATION | 7 0.07 96.94 VENTRICULAR HYPERTROPHY | 6 0.06 97.00 VENTRICULAR TACHYCARDIA | 10 0.10 97.10 VERTIGO | 6 0.06 97.16 VERTIGO POSITIONAL | 2 0.02 97.18 VESTIBULAR DISORDER | 2 0.02 97.20 VICTIM OF CRIME | 1 0.01 97.21 VIRAL INFECTION | 4 0.04 97.25 VIRAL MUTATION IDENTIFIED | 1 0.01 97.26 VISION BLURRED | 24 0.24 97.50 VISUAL ACUITY REDUCED | 15 0.15 97.65 VISUAL DISTURBANCE | 13 0.13 97.78 VISUAL FIELD DEFECT | 5 0.05 97.83 VITAMIN B12 DECREASED | 1 0.01 97.84 VITAMIN B12 DEFICIENCY | 2 0.02 97.86 VITREOUS FLOATERS | 1 0.01 97.87 VOMITING | 69 0.69 98.56 WAIST CIRCUMFERENCE INCREASED | 1 0.01 98.57 WALKING AID USER | 1 0.01 98.58 WARM TYPE HAEMOLYTIC ANAEMIA | 1 0.01 98.59 WEIGHT DECREASED | 49 0.49 99.08 WEIGHT GAIN POOR | 1 0.01 99.09 WEIGHT INCREASED | 26 0.26 99.35 WEIGHT LOSS POOR | 1 0.01 99.36 WHEELCHAIR USER | 1 0.01 99.37 WHEEZING | 4 0.04 99.41 WHIPLASH INJURY | 1 0.01 99.42 WHITE BLOOD CELL COUNT DECREASED | 13 0.13 99.55 WHITE BLOOD CELL COUNT INCREASED | 15 0.15 99.70 WOUND | 3 0.03 99.73 WOUND HAEMORRHAGE | 1 0.01 99.74 WOUND INFECTION | 5 0.05 99.79 WRIST FRACTURE | 2 0.02 99.81 WRONG DRUG ADMINISTERED | 7 0.07 99.88 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 5 0.05 99.93 X-RAY ABNORMAL | 1 0.01 99.94 XANTHOCHROMIA | 1 0.01 99.95 XEROSIS | 1 0.01 99.96 YELLOW SKIN | 4 0.04 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015